HK1245268B - Production method for nitrogen-containing heterocyclic compound, and intermediate of said nitrogen-containing heterocyclic compound - Google Patents
Production method for nitrogen-containing heterocyclic compound, and intermediate of said nitrogen-containing heterocyclic compound Download PDFInfo
- Publication number
- HK1245268B HK1245268B HK18104741.4A HK18104741A HK1245268B HK 1245268 B HK1245268 B HK 1245268B HK 18104741 A HK18104741 A HK 18104741A HK 1245268 B HK1245268 B HK 1245268B
- Authority
- HK
- Hong Kong
- Prior art keywords
- group
- salt
- general formula
- formula
- compound
- Prior art date
Links
Description
技术领域Technical Field
本发明涉及一种作为Fms样酪氨酸激酶3抑制剂有用的含氮杂环化合物的制造方法及其中间体。The present invention relates to a method for producing a nitrogen-containing heterocyclic compound useful as an Fms-like tyrosine kinase 3 inhibitor and intermediates thereof.
背景技术Background Art
Fms样酪氨酸激酶3(FLT3)是属于受体型酪氨酸激酶的III型蛋白质,在N端细胞外结构域具有5个免疫球蛋白样模体(immunoglobulin-like motif),在C端具有2个激酶结构域(kinase domain)。FLT3在正常的CD34阳性人骨髓前体细胞及树突状祖细胞上表达,对这些细胞的增殖/分化等起到重要的作用。并且,FLT3的配体(FL)在骨髓间质细胞及T细胞中表达,是对多数的造血系统的细胞产生造成影响的同时,通过与其他生长因子的相互作用而刺激干细胞、前体细胞、树突状细胞及自然杀伤细胞的增殖的细胞因子之一。Fms-like tyrosine kinase 3 (FLT3) is a type III receptor tyrosine kinase protein with five immunoglobulin-like motifs in its N-terminal extracellular domain and two kinase domains at its C-terminus. FLT3 is expressed on normal CD34-positive human bone marrow progenitor cells and dendritic progenitor cells, playing a crucial role in the proliferation and differentiation of these cells. Furthermore, FLT3's ligand (FL) is expressed in bone marrow stromal cells and T cells. It is a cytokine that influences the production of many hematopoietic cells and, through interaction with other growth factors, stimulates the proliferation of stem cells, progenitor cells, dendritic cells, and natural killer cells.
FLT3若键合FL则进行二聚体化,通过自磷氧化而被活化。其结果,引起PI3及RAS信号传递途径的AKT及ERK的磷氧化。FLT3对造血细胞的增殖/分化起到重要的作用。When FLT3 binds to FL, it dimerizes and becomes activated through autophosphorylation. This leads to the phosphorylation of AKT and ERK, which are involved in the PI3K and RAS signaling pathways. FLT3 plays a crucial role in the proliferation and differentiation of hematopoietic cells.
在正常的骨髓中,FLT3的表达限于早期前体细胞,但在血癌中,由于FLT3以高浓度表达或FLT3发生突变,从而介由上述信号传递途径的活化而有助于癌的增殖恶化。作为血癌,例如包括急性淋巴细胞性白血病(ALL)、急性骨髓性白血病(AML)、急性前骨髓细胞性白血病(APL)、慢性淋巴细胞性白血病(CLL)、慢性骨髓性白血病(CML)、慢性中性粒细胞性白血病(CNL)、急性未分化白血病(AUL)、间变性大细胞淋巴瘤(ALCL)、幼淋巴细胞性白血病(PML)、幼年型骨髓单核细胞性白血病(JMML)、成人T细胞白血病(ATL)、骨髓增生异常综合征(MDS)及骨髓增殖性疾病(MPD)。In normal bone marrow, FLT3 expression is limited to early precursor cells, but in blood cancers, FLT3 is expressed at high concentrations or mutated, thereby contributing to the proliferation and deterioration of cancer through the activation of the above-mentioned signaling pathway. Examples of blood cancers include acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), acute promyelocytic leukemia (APL), chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML), chronic neutrophilic leukemia (CNL), acute undifferentiated leukemia (AUL), anaplastic large cell lymphoma (ALCL), prolymphocytic leukemia (PML), juvenile myelomonocytic leukemia (JMML), adult T-cell leukemia (ATL), myelodysplastic syndrome (MDS), and myeloproliferative disease (MPD).
报道了一种例如,具有优异的FLT3抑制活性,作为医药品的原料药有用的含氮杂环化合物及其制造方法(专利文献1、2)。For example, a nitrogen-containing heterocyclic compound having excellent FLT3 inhibitory activity and useful as a pharmaceutical raw material and a method for producing the same have been reported (Patent Documents 1 and 2).
以往技术文献Previous technical literature
专利文献Patent Literature
专利文献1:国际公开第2013/157540号小册子Patent Document 1: International Publication No. 2013/157540 Pamphlet
专利文献2:国际公开第2015/056683号小册子Patent Document 2: International Publication No. 2015/056683 Pamphlet
发明内容Summary of the Invention
发明要解决的技术课题Technical issues to be solved by the invention
期望一种具有优异的FLT3抑制活性,作为医药品的原料药有用的含氮杂环化合物的工业制造方法。There is a need for an industrial method for producing a nitrogen-containing heterocyclic compound that has excellent FLT3 inhibitory activity and is useful as a raw material for pharmaceuticals.
本发明所要解决的课题在于提供一种具有优异的FLT3抑制活性,作为医药品的原料药有用的含氮杂环化合物的工业制造方法及其中间体。The problem to be solved by the present invention is to provide an industrial production method for a nitrogen-containing heterocyclic compound having excellent FLT3 inhibitory activity and useful as a raw material for pharmaceuticals, and an intermediate thereof.
用于解决技术课题的手段Means for solving technical problems
这种情况下,本发明人等进行不断锐意研究的结果,发现通过以下所示的制造方法能够工业制造具有优异的FLT3抑制活性,作为医药品的原料药有用的含氮杂环化合物。而且,本发明人等发现通式[14]所示的化合物为有用的中间体,从而完成了本发明。Under such circumstances, the present inventors have conducted intensive research and have discovered that a nitrogen-containing heterocyclic compound having excellent FLT3 inhibitory activity and useful as a pharmaceutical raw material can be industrially produced by the production method shown below. Furthermore, the present inventors have discovered that the compound represented by the general formula [14] is a useful intermediate, thereby completing the present invention.
即,本发明提供如下。That is, the present invention provides the following.
<1><1>
一种通式[5]所示的化合物或者其盐的制造方法,A method for producing a compound represented by general formula [5] or a salt thereof,
[化学式5][Chemical Formula 5]
式中,R1表示可被取代的C1-6烷基,该方法包括:In the formula, R1 represents a C1-6 alkyl group which may be substituted, and the method comprises:
使通式[1]所示的化合物或者其盐与通式[2]所示的化合物或者其盐或者六亚甲基四胺反应,制造通式[3]所示的化合物或者其盐之后,根据需要,对得到的化合物或者其盐实施脱保护反应或者水解反应的工序,A step of reacting a compound represented by the general formula [1] or a salt thereof with a compound represented by the general formula [2] or a salt thereof or hexamethylenetetramine to produce a compound represented by the general formula [3] or a salt thereof, and then, if necessary, subjecting the obtained compound or salt thereof to a deprotection reaction or a hydrolysis reaction.
[化学式1][Chemical Formula 1]
式中,R1表示可被取代的C1-6烷基;X1表示离去基,In the formula, R1 represents a C1-6 alkyl group which may be substituted; X1 represents a leaving group,
[化学式2][Chemical Formula 2]
式中,R2表示氢原子或者氨基保护基;R3表示氢原子或者氨基保护基,或者R2及R3成为一体而表示可被取代的邻苯二甲酰基,In the formula, R2 represents a hydrogen atom or an amino-protecting group; R3 represents a hydrogen atom or an amino-protecting group, or R2 and R3 are combined to represent a phthaloyl group which may be substituted.
[化学式3][Chemical Formula 3]
式中,R4表示通式[4]所示的基团或者六亚甲基四胺鎓基;R1具有与上述相同的意思,In the formula, R4 represents a group represented by the general formula [4] or a hexamethylenetetraminium group; R1 has the same meaning as above,
[化学式4][Chemical Formula 4]
式中,*表示键合位置;R2及R3具有与上述相同的意思。In the formula, * represents a bonding position; R 2 and R 3 have the same meanings as above.
<2><2>
一种通式[5]所示的化合物或者其盐的制造方法,A method for producing a compound represented by general formula [5] or a salt thereof,
[化学式12][Chemical Formula 12]
式中,R1具有与上述相同的意思,该方法包括:In the formula, R 1 has the same meaning as above, and the method comprises:
(1)使通式[6]所示的化合物或者其盐与4-氨基苄腈或者其盐反应,制造通式[7]所示的化合物或者其盐的工序;(1) a step of reacting a compound represented by the general formula [6] or a salt thereof with 4-aminobenzonitrile or a salt thereof to produce a compound represented by the general formula [7] or a salt thereof;
[化学式6][Chemical Formula 6]
式中,X2表示离去基;X3表示离去基;R1具有与上述相同的意思,In the formula, X2 represents a leaving group; X3 represents a leaving group; R1 has the same meaning as above,
[化学式7][Chemical Formula 7]
式中,R1及X2具有与上述相同的意思,In the formula, R1 and X2 have the same meanings as above,
(2)使通式[7]所示的化合物或者其盐与通式[8]所示的化合物反应,制造通式[1]所示的化合物或者其盐的工序;以及(2) a step of reacting a compound represented by the general formula [7] or a salt thereof with a compound represented by the general formula [8] to produce a compound represented by the general formula [1] or a salt thereof; and
[化学式8][Chemical Formula 8]
式中,X1具有与上述相同的意思,In the formula, X1 has the same meaning as above,
[化学式9][Chemical Formula 9]
式中,R1及X1具有与上述相同的意思,In the formula, R1 and X1 have the same meanings as above,
(3)使通式[1]所示的化合物或者其盐与通式[2]所示的化合物或者其盐或者六亚甲基四胺反应,制造通式[3]所示的化合物或者其盐之后,根据需要,对得到的化合物或者其盐实施脱保护反应或者水解反应的工序,(3) a step of reacting the compound represented by the general formula [1] or a salt thereof with the compound represented by the general formula [2] or a salt thereof or hexamethylenetetramine to produce the compound represented by the general formula [3] or a salt thereof, and then, if necessary, subjecting the obtained compound or salt thereof to a deprotection reaction or a hydrolysis reaction,
[化学式10][Chemical Formula 10]
式中,R2及R3具有与上述相同的意思,In the formula, R2 and R3 have the same meanings as above,
[化学式11][Chemical Formula 11]
式中,R1及R4具有与上述相同的意思。In the formula, R1 and R4 have the same meanings as above.
<3><3>
根据<1>或者<2>所记载的制造方法,其中,R1为C2-4烷基。The production method according to <1> or <2>, wherein R 1 is a C 2-4 alkyl group.
<4><4>
根据<1>~<3>中任一项所记载的制造方法,其中,R2为C1-6烷氧羰基;R3为C1-6烷氧羰基。The production method according to any one of <1> to <3>, wherein R 2 is a C 1-6 alkoxycarbonyl group; and R 3 is a C 1-6 alkoxycarbonyl group.
<5><5>
根据<2>~<4>中任一项所记载的制造方法,其中,X2为碘原子;X3为氯原子。The production method according to any one of <2> to <4>, wherein X2 is an iodine atom and X3 is a chlorine atom.
<6><6>
一种通式[13]所示的化合物或者其盐的制造方法,A method for producing a compound represented by general formula [13] or a salt thereof,
[化学式21][Chemical Formula 21]
式中,R1、R6及R7具有与上述相同的意思,该方法包括:In the formula, R 1 , R 6 and R 7 have the same meanings as above. The method comprises:
(1)使通式[1]所示的化合物或者其盐与通式[2]所示的化合物或者其盐或者六亚甲基四胺反应,制造通式[3]所示的化合物或者其盐之后,根据需要,对得到的化合物或者其盐实施脱保护反应或者水解反应,制造通式[5]所示的化合物或者其盐的工序;(1) a step of reacting a compound represented by the general formula [1] or a salt thereof with a compound represented by the general formula [2] or a salt thereof or hexamethylenetetramine to produce a compound represented by the general formula [3] or a salt thereof, and then, if necessary, subjecting the obtained compound or salt thereof to a deprotection reaction or a hydrolysis reaction to produce a compound represented by the general formula [5] or a salt thereof;
[化学式13][Chemical Formula 13]
式中,R1及X1具有与上述相同的意思,In the formula, R1 and X1 have the same meanings as above,
[化学式14][Chemical Formula 14]
式中,R2及R3具有与上述相同的意思,In the formula, R2 and R3 have the same meanings as above,
[化学式15][Chemical Formula 15]
式中,R1及R4具有与上述相同的意思,In the formula, R1 and R4 have the same meanings as above,
[化学式16][Chemical Formula 16]
式中,R1具有与上述相同的意思,In the formula, R1 has the same meaning as above,
(2)使通式[5]所示的化合物或者其盐与通式[9]所示的化合物或者其盐反应,制造通式[10]所示的化合物或者其盐的工序;(2) a step of reacting the compound represented by the general formula [5] or a salt thereof with the compound represented by the general formula [9] or a salt thereof to produce the compound represented by the general formula [10] or a salt thereof;
[化学式17][Chemical Formula 17]
式中,R5表示氨基保护基,X4表示羟基或者离去基,In the formula, R 5 represents an amino protecting group, X 4 represents a hydroxyl group or a leaving group,
[化学式18][Chemical Formula 18]
式中,R1及R5具有与上述相同的意思,In the formula, R1 and R5 have the same meanings as above,
(3)对通式[10]所示的化合物或者其盐实施脱保护反应,制造通式[11]所示的化合物或者其盐的工序;以及(3) a step of subjecting the compound represented by the general formula [10] or its salt to a deprotection reaction to produce the compound represented by the general formula [11] or its salt; and
[化学式19][Chemical Formula 19]
式中,R1具有与上述相同的意思,In the formula, R1 has the same meaning as above,
(4)使通式[11]所示的化合物或者其盐与通式[12]所示的化合物或者其盐反应的工序,(4) a step of reacting the compound represented by the general formula [11] or a salt thereof with the compound represented by the general formula [12] or a salt thereof,
[化学式20][Chemical Formula 20]
式中,R6表示氢原子或者可被取代的C1-6烷基;R7表示可被取代的C1-6烷基;X5表示羟基或者离去基。In the formula, R 6 represents a hydrogen atom or a C 1-6 alkyl group which may be substituted; R 7 represents a C 1-6 alkyl group which may be substituted; and X 5 represents a hydroxyl group or a leaving group.
<7><7>
根据<6>所记载的制造方法,其中,R1为C2-4烷基。The production method according to <6>, wherein R1 is a C2-4 alkyl group.
<8><8>
根据<6>或者<7>所记载的制造方法,其中,R2为C1-6烷氧羰基;R3为C1-6烷氧羰基。The production method according to <6> or <7>, wherein R 2 is a C 1-6 alkoxycarbonyl group; and R 3 is a C 1-6 alkoxycarbonyl group.
<9><9>
根据<6>~<8>中任一项所记载的制造方法,其中,R6为C1-4烷基;R7为C1-4烷基。The production method according to any one of <6> to <8>, wherein R6 is a C1-4 alkyl group; and R7 is a C1-4 alkyl group.
<10><10>
一种通式[14]所示的化合物或者其盐,A compound represented by the general formula [14] or a salt thereof,
[化学式22][Chemical Formula 22]
式中,R8表示离去基、通式[4a]所示的基团或者六亚甲基四胺鎓基;R1具有与上述相同的意思,In the formula, R 8 represents a leaving group, a group represented by the general formula [4a] or a hexamethylenetetraminium group; R 1 has the same meaning as above,
[化学式23][Chemical Formula 23]
式中,R2a表示C1-6烷氧羰基;R3a表示C1-6烷氧羰基;*具有与上述相同的意思。In the formula, R 2a represents a C 1-6 alkoxycarbonyl group; R 3a represents a C 1-6 alkoxycarbonyl group; and * has the same meaning as above.
<11><11>
根据<10>所记载的化合物或者其盐,其中,R1为C2-4烷基;R8为离去基。The compound or salt thereof according to <10>, wherein R 1 is C 2-4 alkyl; and R 8 is a leaving group.
<12><12>
根据<10>所记载的化合物或者其盐,其中,R1为C2-4烷基;R8为通式[4a]所示的基团,The compound or salt thereof according to <10>, wherein R 1 is a C 2-4 alkyl group; R 8 is a group represented by the general formula [4a],
[化学式24][Chemical Formula 24]
式中,R2a、R3a及*具有与上述相同的意思。In the formula, R 2a , R 3a and * have the same meanings as above.
<13><13>
一种N2-(4-氰基苯基)-5-碘-N4-丙基嘧啶-2,4-二胺盐酸盐。N 2 -(4-cyanophenyl)-5-iodo-N 4 -propylpyrimidine-2,4-diamine hydrochloride.
发明效果Effects of the Invention
本发明的制造方法作为具有优异的FLT3抑制活性,且作为医药品的原料药有用的含氮杂环化合物的工业制造方法有用。The production method of the present invention is useful as an industrial production method for a nitrogen-containing heterocyclic compound that has excellent FLT3 inhibitory activity and is useful as a raw material for pharmaceuticals.
本发明的化合物作为用于具有优异的FLT3抑制活性,且作为医药品的原料药有用的含氮杂环化合物的工业制造方法的中间体有用。The compound of the present invention is useful as an intermediate in an industrial production process for a nitrogen-containing heterocyclic compound that has excellent FLT3 inhibitory activity and is useful as a raw material for pharmaceuticals.
具体实施方式DETAILED DESCRIPTION
关于本发明,如下进行详细叙述。The present invention will be described in detail below.
本发明中,若无特别限定,则%为质量%。In the present invention, % means mass % unless otherwise specified.
本发明中,若无特别限定,则各术语具有以下的意思。In the present invention, unless otherwise specified, each term has the following meaning.
卤素原子是指氯原子、溴原子或者碘原子。The halogen atom refers to a chlorine atom, a bromine atom or an iodine atom.
C1-6烷基是指甲基、乙基、丙基、异丙基、丁基、仲丁基、异丁基、叔丁基、戊基、异戊基、2-甲基丁基、2-戊基、3-戊基及已基等直链状或者支链状的C1-6烷基。The C 1-6 alkyl group refers to a linear or branched C 1-6 alkyl group such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, isobutyl, tert-butyl, pentyl, isopentyl, 2-methylbutyl, 2-pentyl, 3 - pentyl and hexyl.
C1-4烷基是指甲基、乙基、丙基、异丙基、丁基、仲丁基、异丁基或者叔丁基。C 1-4 alkyl refers to methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, isobutyl or tert-butyl.
C2-4烷基是指乙基、丙基、异丙基、丁基、仲丁基、异丁基或者叔丁基。C 2-4 alkyl refers to ethyl, propyl, isopropyl, butyl, sec-butyl, isobutyl or tert-butyl.
芳基是指苯基或者萘基。Aryl refers to phenyl or naphthyl.
芳C1-6烷基是指苄基、二苯基甲基、三苯甲基、苯乙基、2-苯丙基、3-苯丙基及萘甲基等芳C1-6烷基。Aryl C 1-6 alkyl groups include benzyl, diphenylmethyl, trityl, phenethyl, 2-phenylpropyl, 3-phenylpropyl and naphthylmethyl groups .
C1-6烷氧基是指甲氧基、乙氧基、丙氧基、异丙氧基、丁氧基、异丁氧基、仲丁氧基、叔丁氧基、戊氧基和己氧基等直链状或者支链状的C1-6烷氧基。The C 1-6 alkoxy group refers to a linear or branched C 1-6 alkoxy group such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, sec-butoxy, tert-butoxy, pentyloxy and hexyloxy.
C1-6烷氧基C1-6烷基是指甲氧基甲基及1-乙氧基乙基等C1-6烷氧基C1-6烷基。C 1-6 alkoxy C 1-6 alkyl refers to C 1-6 alkoxy C 1-6 alkyl such as methoxymethyl and 1-ethoxyethyl.
C2-6烷酰基是指乙酰基、丙酰基、戊酰基、异戊酰基及新戊酰基等直链状或者支链状C2-6烷酰基。The C 2-6 alkanoyl group refers to a linear or branched C 2-6 alkanoyl group such as acetyl, propionyl, valeryl, isovaleryl and pivaloyl.
芳酰基是指苯甲酰基或者萘甲酰基。Aroyl refers to benzoyl or naphthoyl.
杂环式羰基是指糠酰基、噻吩甲酰基、吡咯烷基羰基、哌啶基羰基、哌嗪基羰基、吗啉基羰基或者吡啶基羰基。The heterocyclic carbonyl group refers to a furoyl group, a thenoyl group, a pyrrolidinylcarbonyl group, a piperidinylcarbonyl group, a piperazinylcarbonyl group, a morpholinylcarbonyl group or a pyridylcarbonyl group.
酰基是指甲酰基、C2-6烷酰基、芳酰基或者杂环式羰基。The acyl group is a formyl group, a C 2-6 alkanoyl group, an aroyl group or a heterocyclic carbonyl group.
C1-6烷氧羰基是指甲氧基羰基、乙氧基羰基、丙氧基羰基、异丙氧基羰基、叔丁氧基羰基及1,1-二甲基丙氧基羰基等直链状或者支链状C1-6烷氧基羰基。The C 1-6 alkoxycarbonyl group refers to a linear or branched C 1-6 alkoxycarbonyl group such as methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, tert-butoxycarbonyl, and 1,1-dimethylpropoxycarbonyl.
C3-6烷氧羰基是指丙氧羰基、异丙氧基羰基、叔丁氧基羰基及1,1-二甲基丙氧基羰基等直链状或者支链状C3-6烷氧基羰基。The C 3-6 alkoxycarbonyl group refers to a linear or branched C 3-6 alkoxycarbonyl group such as a propoxycarbonyl group, an isopropoxycarbonyl group, a tert-butoxycarbonyl group, and a 1,1-dimethylpropoxycarbonyl group.
芳C1-6烷氧羰基是指苄氧基羰基及苯乙氧基羰基等芳C1-6烷氧基羰基。The aryl C 1-6 alkoxycarbonyl group includes aryl C 1-6 alkoxycarbonyl groups such as benzyloxycarbonyl and phenethoxycarbonyl.
芳氧基羰基是指苯氧基羰基或者萘氧基羰基。The aryloxycarbonyl group refers to a phenoxycarbonyl group or a naphthoxycarbonyl group.
C1-6烷基氨基是指甲基氨基、乙基氨基、丙基氨基、异丙基氨基、丁基氨基、仲丁基氨基、叔丁基氨基、戊基氨基及己基氨基等直链状或者支链状C1-6烷基氨基。The C 1-6 alkylamino group refers to a linear or branched C 1-6 alkylamino group such as methylamino, ethylamino, propylamino, isopropylamino, butylamino, sec-butylamino, tert-butylamino, pentylamino, and hexylamino.
二(C1-6烷基)氨基是指二甲氨基、二乙氨基、二丙氨基、二异丙基氨基、二丁基氨基、二(叔丁基)氨基、戊氨基、二正己胺、(乙基)(甲基)氨基及(甲基)(丙基)氨基等直链状或者支链状二(C1-6烷基)氨基。The di(C 1-6 alkyl)amino group refers to a linear or branched di(C 1-6 alkyl)amino group such as dimethylamino, diethylamino, dipropylamino, diisopropylamino, dibutylamino, di(tert-butyl)amino, pentylamino, di-n-hexylamino, (ethyl)(methyl)amino, and (methyl)( propyl )amino.
C1-6烷基磺酰基是指甲基磺酰基、乙基磺酰基及丙基磺酰基等C1-6烷基磺酰基。The C 1-6 alkylsulfonyl group refers to a C 1-6 alkylsulfonyl group such as a methylsulfonyl group, an ethylsulfonyl group, and a propylsulfonyl group.
芳基磺酰基是指苯磺酰基、对甲苯磺酰基或者萘磺酰基。The arylsulfonyl group refers to a benzenesulfonyl group, a p-toluenesulfonyl group or a naphthylsulfonyl group.
C1-6烷基磺酰氧基是指甲基磺酰氧基及乙基磺酰氧基等C1-6烷基磺酰氧基。The C 1-6 alkylsulfonyloxy group refers to a C 1-6 alkylsulfonyloxy group such as a methylsulfonyloxy group and an ethylsulfonyloxy group.
芳基磺酰氧基是指苯磺酰氧基或者对甲苯磺酰氧基。The arylsulfonyloxy group refers to a benzenesulfonyloxy group or a p-toluenesulfonyloxy group.
甲硅烷基是指三甲基硅烷基、三乙基硅烷基或者三丁基硅烷基。The silyl group refers to a trimethylsilyl group, a triethylsilyl group or a tributylsilyl group.
离去基是指卤素原子、C1-6烷基磺酰氧基或者芳基磺酰氧基。C1-6烷基磺酰氧基及芳基磺酰氧基可被选自取代基群A的一个以上的基团取代。The leaving group is a halogen atom, a C 1-6 alkylsulfonyloxy group or an arylsulfonyloxy group. The C 1-6 alkylsulfonyloxy group and the arylsulfonyloxy group may be substituted with one or more groups selected from the substituent group A.
取代基群A及取代基群B分别指以下基团。Substituent Group A and Substituent Group B respectively refer to the following groups.
取代基群A:氟原子、卤素原子、氰基、可被保护的氨基、可被保护的羟基、C1-6烷基、芳基、C1-6烷氧基、C1-6烷基氨基、二(C1-6烷基)氨基、桥氧基。Substituent group A: fluorine atom, halogen atom, cyano group, optionally protected amino group, optionally protected hydroxyl group, C 1-6 alkyl group, aryl group, C 1-6 alkoxy group, C 1-6 alkylamino group, di(C 1-6 alkyl)amino group, and oxo group.
取代基群B:氟原子、卤素原子、C1-6烷基、C1-6烷氧基。Substituent group B: fluorine atom, halogen atom, C 1-6 alkyl group, C 1-6 alkoxy group.
作为氨基保护基,包括作为通常的氨基的保护基可使用的所有基团,例如可举出有机合成中的保护基(Greene's Protective Groups in Organic Synthesis)第5版、第895~1193页、2014年、John Wiley&Sons,INC.所记载的基团。具体而言,可举出芳C1-6烷基、C1-6烷氧基C1-6烷基、酰基、C1-6烷氧羰基、芳C1-6烷氧羰基、芳氧基羰基、C1-6烷基磺酰基、芳基磺酰基或者甲硅烷基。这些基团可被选自取代基群A的一个以上的基团取代。As amino-protecting groups, all groups that can be used as conventional amino-protecting groups are included, and examples thereof include those described in Greene's Protective Groups in Organic Synthesis, 5th edition, pages 895-1193, 2014, John Wiley & Sons, Inc. Specifically, examples include aryl C 1-6 alkyl, C 1-6 alkoxy C 1-6 alkyl, acyl, C 1-6 alkoxycarbonyl, aryl C 1-6 alkoxycarbonyl, aryloxycarbonyl, C 1-6 alkylsulfonyl , arylsulfonyl, and silyl. These groups may be substituted with one or more groups selected from Substituent Group A.
作为羟基保护基,包括作为通常的羟基的保护基可使用的所有基团,例如,有机合成中的绿色保护基(Greene's Protective Groups in Organic Synthesis)第5版、第17~471页、2014年、John Wiley&Sons,INC.所记载的基团。具体而言,例如可举出C1-6烷基、芳C1-6烷基、C1-6烷氧基C1-6烷基、酰基、C1-6烷氧羰基、芳C1-6烷氧羰基、C1-6烷基磺酰基、芳基磺酰基、甲硅烷基、四氢呋喃基或者四氢吡喃基。这些基团可被选自取代基群A的一个以上的基团取代。The hydroxyl protecting group includes all groups that can be used as a conventional hydroxyl protecting group, for example, the groups described in Greene's Protective Groups in Organic Synthesis, 5th edition, pages 17-471, 2014, John Wiley & Sons, Inc. Specific examples include C 1-6 alkyl, aryl C 1-6 alkyl, C 1-6 alkoxy C 1-6 alkyl, acyl, C 1-6 alkoxycarbonyl, aryl C 1-6 alkoxycarbonyl, C 1-6 alkylsulfonyl, arylsulfonyl, silyl, tetrahydrofuranyl, or tetrahydropyranyl. These groups may be substituted with one or more groups selected from substituent group A.
脂肪族烃类是指戊烷、己烷、庚烷、环己烷、甲基环己烷或者乙基环己烷。The aliphatic hydrocarbons include pentane, hexane, heptane, cyclohexane, methylcyclohexane or ethylcyclohexane.
卤化烃类是指二氯甲烷、氯仿或者二氯乙烷。Halogenated hydrocarbons refer to dichloromethane, chloroform or dichloroethane.
醚类是指二乙醚、二异丙醚、四氢呋喃、2-甲基四氢呋喃、1,4-二恶烷、苯甲醚、乙二醇二甲醚、二甘醇二甲醚或者二乙二醇二乙醚。The ethers include diethyl ether, diisopropyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, anisole, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether or diethylene glycol diethyl ether.
醇类是指甲醇、乙醇、丙醇、2-丙醇、丁醇、2-甲基-2-丙醇、乙二醇、丙二醇或者二甘醇。Alcohols include methanol, ethanol, propanol, 2-propanol, butanol, 2-methyl-2-propanol, ethylene glycol, propylene glycol, or diethylene glycol.
酮类是指丙酮、2-丁酮或者4-甲基-2-戊酮。Ketones refer to acetone, 2-butanone or 4-methyl-2-pentanone.
酯类是指乙酸甲酯、乙酸乙酯、乙酸丙酯、乙酸异丙酯或者乙酸丁酯。Esters refer to methyl acetate, ethyl acetate, propyl acetate, isopropyl acetate or butyl acetate.
酰胺类是指N,N-二甲基甲酰胺、N,N-二甲基乙酰胺或者N-甲基吡咯烷酮。Amides refer to N,N-dimethylformamide, N,N-dimethylacetamide or N-methylpyrrolidone.
腈类是指乙腈或者丙腈。Nitriles refer to acetonitrile or propionitrile.
亚砜类是二甲基亚砜或者环丁砜。The sulfoxide is dimethyl sulfoxide or sulfolane.
芳香族烃类是指苯、甲苯或者二甲苯。Aromatic hydrocarbons refer to benzene, toluene or xylene.
无机碱是指氢氧化钠、氢氧化钾、甲醇钠、叔丁氧基钠、叔丁氧基钾、碳酸氢钠、碳酸钠、碳酸钾、磷酸三钾、乙酸钾、氟化铯或者碳酸铯。The inorganic base refers to sodium hydroxide, potassium hydroxide, sodium methoxide, sodium tert-butoxide, potassium tert-butoxide, sodium bicarbonate, sodium carbonate, potassium carbonate, tripotassium phosphate, potassium acetate, cesium fluoride or cesium carbonate.
有机碱是指三乙胺、N,N-二异丙基乙胺、1,8-二氮杂双环(5.4.0)十一碳-7-烯(DBU)、吡啶、4-萘甲酰吡啶或者N-甲基吗啉。The organic base refers to triethylamine, N,N-diisopropylethylamine, 1,8-diazabicyclo(5.4.0)undec-7-ene (DBU), pyridine, 4-naphthoylpyridine or N-methylmorpholine.
作为通式[1]、[2]、[3]、[5]、[6]、[7]、[9]、[10]、[11]、[12]、[13]及[14]的化合物的盐,可举出通常公知的氨基等的碱性基团以及羟基及羧基等的酸性基团中的盐。Examples of salts of the compounds of the general formulae [1], [2], [3], [5], [6], [7], [9], [10], [11], [12], [13] and [14] include salts of generally known basic groups such as amino groups and acidic groups such as hydroxyl groups and carboxyl groups.
作为碱性基团中的盐,例如可举出与盐酸、氢溴酸、硝酸、硫酸等无机酸的盐;与甲酸、乙酸、柠檬酸、草酸、富马酸、马来酸、琥珀酸、苹果酸、酒石酸、天冬氨酸、三氯乙酸及三氟乙酸等有机羧酸的盐;以及与甲磺酸、苯磺酸、对甲苯磺酸、均三甲苯磺酸及萘磺酸等磺酸的盐等。Examples of the salt of the basic group include salts with inorganic acids such as hydrochloric acid, hydrobromic acid, nitric acid, and sulfuric acid; salts with organic carboxylic acids such as formic acid, acetic acid, citric acid, oxalic acid, fumaric acid, maleic acid, succinic acid, malic acid, tartaric acid, aspartic acid, trichloroacetic acid, and trifluoroacetic acid; and salts with sulfonic acids such as methanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, mesitylenesulfonic acid, and naphthalenesulfonic acid.
作为酸性基团中的碱,例如可举出与钠及钾等碱金属的盐;与钙及镁等碱土金属的盐;铵盐;以及与三甲胺、三乙胺、三丁胺、吡啶、N,N-二甲基苯胺、N-甲基哌啶、N-甲基吗啉、二乙胺、二环己胺、普鲁卡因、二环己基胺、N-溴-β-苯乙胺、1-二苯羟甲胺及N,N’-二苄基乙二胺等含氮有机碱的盐等。Examples of the base in the acidic group include salts with alkali metals such as sodium and potassium; salts with alkaline earth metals such as calcium and magnesium; ammonium salts; and salts with nitrogen-containing organic bases such as trimethylamine, triethylamine, tributylamine, pyridine, N,N-dimethylaniline, N-methylpiperidine, N-methylmorpholine, diethylamine, dicyclohexylamine, procaine, dicyclohexylamine, N-bromo-β-phenylethylamine, 1-diphenylhydroxymethylamine, and N,N'-dibenzylethylenediamine.
上述的盐中,作为优选的盐,可举出药理学上可允许的盐。Among the above-mentioned salts, preferred salts include pharmacologically acceptable salts.
R1为可被取代的C1-6烷基。R 1 is a C 1-6 alkyl group which may be substituted.
R1的C1-6烷基可被选自取代基群A的一个以上的基团取代。The C 1-6 alkyl group of R 1 may be substituted by one or more groups selected from the substituent group A.
R1优选为C1-6烷基,更优选为C2-4烷基,进一步优选为丙基。R 1 is preferably a C 1-6 alkyl group, more preferably a C 2-4 alkyl group, and further preferably a propyl group.
R2为氢原子或者氨基保护基。 R2 is a hydrogen atom or an amino protecting group.
R2优选为氨基保护基,更优选为C1-6烷氧羰基,进一步优选为C3-6烷氧羰基,尤其优选为叔丁氧基羰基。R 2 is preferably an amino protecting group, more preferably a C 1-6 alkoxycarbonyl group, further preferably a C 3-6 alkoxycarbonyl group, and particularly preferably a tert-butoxycarbonyl group.
R3为氢原子或者氨基保护基。R 3 is a hydrogen atom or an amino protecting group.
R3优选为氨基保护基,更优选为C1-6烷氧羰基,进一步优选为C3-6烷氧羰基,尤其优选为叔丁氧基羰基。R 3 is preferably an amino protecting group, more preferably a C 1-6 alkoxycarbonyl group, further preferably a C 3-6 alkoxycarbonyl group, and particularly preferably a tert-butoxycarbonyl group.
R2及R3可成为一体而形成可被取代的邻苯二甲酰基团。R 2 and R 3 may be combined to form a phthaloyl group which may be substituted.
R2及R3成为一体而形成的邻苯二甲酰基可被选自取代基群A的一个以上的基团取代。The phthaloyl group formed by combining R 2 and R 3 may be substituted with one or more groups selected from the substituent group A.
R2及R3优选成为一体而为邻苯二甲酰基。It is preferred that R 2 and R 3 be combined to form a phthaloyl group.
R2a为C1-6烷氧羰基。R 2a is a C 1-6 alkoxycarbonyl group.
R2a优选为C3-6烷氧羰基,更优选为叔丁氧基羰基。R 2a is preferably a C 3-6 alkoxycarbonyl group, more preferably a tert-butoxycarbonyl group.
R3a为C1-6烷氧羰基。R 3a is a C 1-6 alkoxycarbonyl group.
R3a优选为C3-6烷氧羰基,更优选为叔丁氧基羰基。R 3a is preferably a C 3-6 alkoxycarbonyl group, more preferably a tert-butoxycarbonyl group.
R4为通式[4]R 4 is the general formula [4]
[化学式25][Chemical Formula 25]
(式中,R2、R3及*具有与上述相同的意思)所示的基团或者六亚甲基四胺鎓基。(wherein R 2 , R 3 and * have the same meanings as above) or a hexamethylenetetraminium group.
R4优选为通式[4]所示的基团。R 4 is preferably a group represented by the general formula [4].
优选的R2与上述相同。Preferred R 2 is the same as described above.
优选的R3与上述相同。Preferred R 3 is the same as described above.
R5为氨基保护基。 R5 is an amino protecting group.
R5优选为C1-6烷氧羰基,更优选为叔丁氧基羰基。R 5 is preferably a C 1-6 alkoxycarbonyl group, more preferably a tert-butoxycarbonyl group.
R6为氢原子或者可被取代的C1-6烷基。R 6 is a hydrogen atom or an optionally substituted C 1-6 alkyl group.
R6的C1-6烷基可被选自取代基群A的一个以上的基团取代。The C 1-6 alkyl group of R 6 may be substituted by one or more groups selected from the substituent group A.
R6优选为C1-6烷基,更优选为C1-4烷基,进一步优选为甲基。R 6 is preferably a C 1-6 alkyl group, more preferably a C 1-4 alkyl group, and further preferably a methyl group.
R7为可被取代的C1-6烷基。R 7 is a C 1-6 alkyl group which may be substituted.
R7的C1-6烷基可被选自取代基群A的一个以上的基团取代。The C 1-6 alkyl group of R 7 may be substituted by one or more groups selected from the substituent group A.
R7优选为C1-6烷基,更优选为C1-4烷基,进一步优选为甲基。R 7 is preferably a C 1-6 alkyl group, more preferably a C 1-4 alkyl group, and further preferably a methyl group.
R8为离去基、通式[4a]R 8 is a leaving group, general formula [4a]
[化学式26][Chemical Formula 26]
(式中,R2a、R3a及*具有与上述相同的意思)所示的基团或者六亚甲基四胺鎓基。(wherein R 2a , R 3a and * have the same meanings as above) or a hexamethylenetetraminium group.
R8优选为离去基或者通式[4a]所示的基团。R 8 is preferably a leaving group or a group represented by the general formula [4a].
R8为离去基的情况下,优选为卤素原子,更优选为氯原子。When R 8 is a leaving group, it is preferably a halogen atom, more preferably a chlorine atom.
R8为通式[4a]所示的基团的情况下,优选为R2a是C3-6烷氧羰基,R3a是C3-6烷氧羰基的通式[4a]所示的基团,更优选为二(叔丁氧基羰基)氨基。When R 8 is a group represented by the general formula [4a], preferably, R 2a is a C 3-6 alkoxycarbonyl group and R 3a is a group represented by the general formula [4a] in which R 2a is a C 3-6 alkoxycarbonyl group and R 3a is a C 3-6 alkoxycarbonyl group, and more preferably, it is a di(tert-butoxycarbonyl)amino group.
优选的R2a与上述相同。Preferred R 2a are the same as described above.
优选的R3a与上述相同。Preferred R 3a are the same as described above.
X1为离去基。 X1 is a leaving group.
X1优选为选自卤素原子、可被选自取代基群B的一个以上的基团取代的C1-6烷基磺酰氧基或者可被选自取代基群B的一个以上的基团取代的芳基磺酰氧基,更优选为卤素原子,进一步优选为氯原子。 X1 is preferably a halogen atom, a C1-6 alkylsulfonyloxy group which may be substituted with one or more groups selected from the substituent group B, or an arylsulfonyloxy group which may be substituted with one or more groups selected from the substituent group B, more preferably a halogen atom, and even more preferably a chlorine atom.
X2为离去基。 X2 is a leaving group.
X2优选为卤素原子,更优选为碘原子。 X2 is preferably a halogen atom, more preferably an iodine atom.
X3为离去基。X 3 is a leaving group.
X3优选为卤素原子,更优选为氯原子。X 3 is preferably a halogen atom, more preferably a chlorine atom.
X4为羟基或者离去基。 X4 is a hydroxyl group or a leaving group.
X4优选为羟基。X 4 is preferably a hydroxyl group.
X4为离去基的情况下,X4优选为卤素原子,更优选为氯原子。When X4 is a leaving group, X4 is preferably a halogen atom, more preferably a chlorine atom.
X5为羟基或者离去基。 X5 is a hydroxyl group or a leaving group.
X5优选为羟基。X 5 is preferably a hydroxyl group.
X5为离去基的情况下,X5优选为卤素原子,更优选为氯原子。When X 5 is a leaving group, X 5 is preferably a halogen atom, more preferably a chlorine atom.
通式[14]的化合物或者其盐中,存在异构体(例如,光学异构体、几何异构体及互変异构体等)的情况下,本发明包含这些异构体,包含酐、溶剂化物、水合物和各种形状的晶体。When the compound of the general formula [14] or a salt thereof has isomers (eg, optical isomers, geometric isomers, and tautomers), the present invention encompasses these isomers, including anhydrides, solvates, hydrates, and crystals of various shapes.
接着,对本发明化合物进行说明。Next, the compound of the present invention is described.
本发明化合物为通式[14]The compound of the present invention is of the general formula [14]
[化学式27][Chemical Formula 27]
(式中,R1及R8具有与上述相同的意思)所示的化合物或者其盐。(wherein R 1 and R 8 have the same meanings as above) or a salt thereof.
优选的R1与上述相同。Preferred R 1 is the same as described above.
优选的R8与上述相同。Preferred R 8 is the same as described above.
接着,对本发明的制造方法进行说明。Next, the production method of the present invention will be described.
[制造方法A][Manufacturing method A]
[化学式28][Chemical Formula 28]
(式中,R1、X1、X2及X3具有与上述相同的意思)(wherein, R 1 , X 1 , X 2 and X 3 have the same meanings as above)
<第1工序><Step 1>
作为通式[6]所示的化合物,已知例如2-氯-5-碘-N-丙基嘧啶-4-胺等。As the compound represented by the general formula [6], for example, 2-chloro-5-iodo-N-propylpyrimidin-4-amine is known.
通式[7]所示的化合物或者其盐能够通过在酸的存在下,对通式[6]所示的化合物或者其盐使4-氨基苄腈或者其盐反应来制造。The compound represented by the general formula [7] or a salt thereof can be produced by reacting the compound represented by the general formula [6] or a salt thereof with 4-aminobenzonitrile or a salt thereof in the presence of an acid.
作为该反应所使用的溶剂,只要不对反应造成影响则没有特别限定,但可举出例如,脂肪族烃类、卤化烃类、醚类、酯类、酰胺类、腈类、亚砜类及芳香族烃类,这些溶剂也可以混合使用。The solvent used in the reaction is not particularly limited as long as it does not affect the reaction, and examples thereof include aliphatic hydrocarbons, halogenated hydrocarbons, ethers, esters, amides, nitriles, sulfoxides, and aromatic hydrocarbons. These solvents may also be used as a mixture.
作为优选的溶剂可举出酰胺类,更优选N,N-二甲基甲酰胺、N,N-二甲基乙酰胺及N-甲基吡咯烷酮,进一步优选N-甲基吡咯烷酮。Preferred solvents include amides, more preferably N,N-dimethylformamide, N,N-dimethylacetamide, and N-methylpyrrolidone, and further preferably N-methylpyrrolidone.
溶剂的使用量没有特别限定,但相对于通式[6]所示的化合物或者其盐,为1~500倍量(v/w)即可。The amount of the solvent used is not particularly limited, but may be 1 to 500 times (v/w) the amount of the compound represented by the general formula [6] or a salt thereof.
作为该反应所使用的酸,可举出盐酸、氢溴酸、硝酸及硫酸等的无机酸;以及甲磺酸、苯磺酸、对甲苯磺酸、均三甲苯磺酸、萘磺酸及樟脑磺酸等磺酸,优选盐酸及樟脑磺酸,更优选盐酸。Examples of the acid used in the reaction include inorganic acids such as hydrochloric acid, hydrobromic acid, nitric acid and sulfuric acid; and sulfonic acids such as methanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, mesitylenesulfonic acid, naphthalenesulfonic acid and camphorsulfonic acid. Preferred are hydrochloric acid and camphorsulfonic acid, and more preferred is hydrochloric acid.
酸的使用量相对于通式[6]所示的化合物或者其盐,为0.5~5倍摩尔即可。The amount of the acid used may be 0.5 to 5 times the molar amount of the compound represented by the general formula [6] or a salt thereof.
4-氨基苄腈的使用量相对于通式[6]所示的化合物或者其盐为1~50倍摩尔,优选为1~5倍摩尔即可。The amount of 4-aminobenzonitrile used is 1 to 50 times the mole, preferably 1 to 5 times the mole, of the compound represented by the general formula [6] or a salt thereof.
该反应在-30~150℃下,优选在0~100℃下实施30分钟~48小时即可。The reaction can be carried out at -30 to 150°C, preferably at 0 to 100°C, for 30 minutes to 48 hours.
通式[7]所示的化合物优选作为盐而分离。作为优选的盐,可举出盐酸盐。通过作为盐酸盐而分离,能够以高收率、高纯度及简单的操作得到通式[7]所示的化合物。The compound represented by the general formula [7] is preferably isolated as a salt. A preferred salt is a hydrochloride. By isolating it as a hydrochloride, the compound represented by the general formula [7] can be obtained with high yield, high purity, and simple operation.
<第2工序><Step 2>
作为通式[8]所示的化合物,已知例如5-氯-1-戊炔等。As the compound represented by the general formula [8], for example, 5-chloro-1-pentyne is known.
通式[1]所示的化合物或者其盐能够通过在钯催化剂的存在下、铜盐的存在下及碱的存在下,对通式[7]所示的化合物或者其盐使通式[8]所示的化合物反应来制造。The compound represented by the general formula [1] or a salt thereof can be produced by reacting the compound represented by the general formula [8] with the compound represented by the general formula [7] or a salt thereof in the presence of a palladium catalyst, a copper salt and a base.
作为该反应所使用的溶剂,只要不对反应造成影响则没有特别限定,但可举出例如,脂肪族烃类、卤化烃类、醚类、酯类、酰胺类、腈类、亚砜类及芳香族烃类,这些溶剂也可以混合使用。The solvent used in the reaction is not particularly limited as long as it does not affect the reaction, and examples thereof include aliphatic hydrocarbons, halogenated hydrocarbons, ethers, esters, amides, nitriles, sulfoxides, and aromatic hydrocarbons. These solvents may also be used as a mixture.
作为优选的溶剂可举出醚类及酰胺类,更优选四氢呋喃及N,N-二甲基甲酰胺,进一步优选四氢呋喃。Preferred solvents include ethers and amides, more preferred are tetrahydrofuran and N,N-dimethylformamide, and even more preferred is tetrahydrofuran.
溶剂的使用量没有特别限定,但相对于通式[7]所示的化合物或者其盐为1~500倍量(v/w)即可。The amount of the solvent used is not particularly limited, but may be 1 to 500 times (v/w) the amount of the compound represented by the general formula [7] or a salt thereof.
通式[8]所示的化合物的使用量相对于通式[7]所示的化合物或者其盐为1~50倍摩尔,优选1~5倍摩尔即可。The amount of the compound represented by the general formula [8] used is 1 to 50 times the mole, preferably 1 to 5 times the mole, of the compound represented by the general formula [7] or a salt thereof.
作为该反应所使用的钯催化剂,钯-碳和钯黑等金属钯;氯化钯等无机钯盐;醋酸钯等有机钯盐;(2-(二环己基膦基)-3,6-二甲氧基-2',4',6'-三异丙基-1,1'-双基)(2-(2-氨基乙基)苯基)钯(II);四(三苯基膦)钯(0)、二(三苯基膦)二氯化钯(II)、双(二-叔丁基(4-二甲基氨基苯基)膦)二氯钯(II)、1,1'-双(二基膦基)二茂铁二氯化钯(II)、(E)-二(μ-乙酸酯)双(邻-(邻二甲苯基膦基)苄基)二钯(II)及三(二亚苄基丙酮)二钯(0)等有机钯络合物以及聚合物负载的双(乙酸酯)三基膦钯(II)及聚合物负载的二(乙酸酯)二环己基膦钯(II)等聚合物负载的有机钯络合物等,优选有机钯络合物。The palladium catalyst used in the reaction includes metal palladium such as palladium-carbon and palladium black; inorganic palladium salts such as palladium chloride; organic palladium salts such as palladium acetate; (2-(dicyclohexylphosphino)-3,6-dimethoxy-2',4',6'-triisopropyl-1,1'-diyl)(2-(2-aminoethyl)phenyl)palladium(II); tetrakis(triphenylphosphine)palladium(0), bis(triphenylphosphine)palladium(II) dichloride, bis(di-tert-butyl(4-dimethylaminophenyl)phosphine)di Organic palladium complexes such as chloropalladium (II), 1,1'-bis(dimethylphosphino)ferrocene dichloropalladium (II), (E)-bis(μ-acetate)bis(o-(o-xylylphosphino)benzyl)dipalladium (II) and tris(dibenzylideneacetone)dipalladium (0), and polymer-supported organic palladium complexes such as bis(acetate)trimethylphosphine palladium (II) and polymer-supported bis(acetate)dicyclohexylphosphine palladium (II), etc., are preferred.
钯催化剂的使用量相对于通式[7]所示的化合物或者其盐为0.0001~2倍摩尔,优选0.001~0.2倍摩尔即可。The amount of the palladium catalyst used is 0.0001 to 2 times the mole of the compound represented by the general formula [7] or a salt thereof, preferably 0.001 to 0.2 times the mole.
作为该反应所使用的铜盐可举出氯化铜(I)、溴化铜(I)、碘化铜(I)及乙酸铜(II),优选碘化铜(I)。Examples of the copper salt used in the reaction include copper (I) chloride, copper (I) bromide, copper (I) iodide, and copper (II) acetate, with copper (I) iodide being preferred.
铜盐的使用量相对于通式[7]所示的化合物或者其盐为0.0001~2倍摩尔,优选0.001~0.5倍摩尔即可。The amount of the copper salt used is 0.0001 to 2 times the mole of the compound represented by the general formula [7] or a salt thereof, preferably 0.001 to 0.5 times the mole.
作为该反应所使用的碱,可举出有机碱,优选三乙胺及N,N-二异丙基乙胺,更优选三乙胺。Examples of the base used in this reaction include organic bases, preferably triethylamine and N,N-diisopropylethylamine, and more preferably triethylamine.
碱的使用量相对于通式[7]所示的化合物或者其盐为0.1~50倍摩尔,优选1~10倍摩尔即可。The amount of the base used is 0.1 to 50 times the mole, preferably 1 to 10 times the mole, of the compound represented by the general formula [7] or a salt thereof.
该反应在-30~150℃下,优选在0~100℃下实施30分钟~48小时即可。The reaction can be carried out at -30 to 150°C, preferably at 0 to 100°C, for 30 minutes to 48 hours.
作为该工序,优选使用5-氯-1-戊炔的制造方法。As this step, a method for producing 5-chloro-1-pentyne is preferably used.
通过使用5-氯-1-戊炔的制造方法,能够以高收率、高纯度及简便的操作制造通式[1]所示的化合物或者其盐。By using the production method of 5-chloro-1-pentyne, the compound represented by the general formula [1] or a salt thereof can be produced with high yield, high purity and simple operation.
并且,通式[1]所示的化合物或者其盐为稳定的化合物,操作处理容易。Furthermore, the compound represented by the general formula [1] or a salt thereof is a stable compound and can be easily handled.
作为来自通式[7]所示的化合物或者其盐的通式[1]所示的化合物或者其盐的制造方法,还能够使用以下的方法。As a method for producing the compound represented by the general formula [1] or a salt thereof from the compound represented by the general formula [7] or a salt thereof, the following method can also be used.
[化学式29][Chemical Formula 29]
(式中,R1、X1及X2具有与上述相同的意思)(wherein, R 1 , X 1 and X 2 have the same meanings as above)
通式[15]所示的化合物或者其盐能够通过在钯催化剂的存在下、铜盐的存在下及碱的存在下,对通式[7]所示的化合物或者其盐使4-戊炔-1-醇反应来制造。The compound represented by the general formula [15] or a salt thereof can be produced by reacting the compound represented by the general formula [7] or a salt thereof with 4-pentyn-1-ol in the presence of a palladium catalyst, a copper salt and a base.
该反应按照制造方法A<第2工序>来进行即可。This reaction may be carried out according to Production Method A <Step 2>.
通式[1]所示的化合物或者其盐能够通过在碱的存在下,对通式[15]所示的化合物或者其盐使磺酰卤反应来制造。The compound represented by the general formula [1] or a salt thereof can be produced by reacting a compound represented by the general formula [15] or a salt thereof with a sulfonyl halide in the presence of a base.
作为该反应所使用的溶剂,只要不对反应造成影响则没有特别限定,但可举出例如,脂肪族烃类、卤化烃类、醚类、酯类、酰胺类、腈类、亚砜类及芳香族烃类,这些溶剂也可以混合使用。The solvent used in the reaction is not particularly limited as long as it does not affect the reaction, and examples thereof include aliphatic hydrocarbons, halogenated hydrocarbons, ethers, esters, amides, nitriles, sulfoxides, and aromatic hydrocarbons. These solvents may also be used as a mixture.
作为优选的溶剂可举出卤化烃类、醚类及酰胺类,更优选卤化烃类。Preferred solvents include halogenated hydrocarbons, ethers, and amides, with halogenated hydrocarbons being more preferred.
溶剂的使用量没有特别限定,但相对于通式[15]所示的化合物或者其盐为1~500倍量(v/w)即可。The amount of the solvent used is not particularly limited, but may be 1 to 500 times (v/w) the amount of the compound represented by the general formula [15] or a salt thereof.
作为该反应所使用的磺酰卤,可举出例如,甲磺酰氯、三氟甲磺酰氯、苯磺酰氯及对甲苯磺酰氯。Examples of the sulfonyl halide used in the reaction include methanesulfonyl chloride, trifluoromethanesulfonyl chloride, benzenesulfonyl chloride and p-toluenesulfonyl chloride.
作为优选的磺酰卤,可举出甲磺酰氯及对甲苯磺酰氯。Preferred examples of the sulfonyl halide include methanesulfonyl chloride and p-toluenesulfonyl chloride.
磺酰卤的使用量相对于通式[15]所示的化合物或者其盐为1~10倍摩尔,优选1~5倍摩尔即可。The amount of the sulfonyl halide used is 1 to 10 times the mole, preferably 1 to 5 times the mole, of the compound represented by the general formula [15] or a salt thereof.
作为该反应所使用的碱可举出有机碱,优选三乙胺及N,N-二异丙基乙胺。Examples of the base used in this reaction include organic bases, with triethylamine and N,N-diisopropylethylamine being preferred.
碱的使用量相对于通式[15]所示的化合物或者其盐为1~10倍摩尔,优选1~5倍摩尔即可。The amount of the base used is 1 to 10 times the mole, preferably 1 to 5 times the mole, of the compound represented by the general formula [15] or a salt thereof.
该反应在-30~150℃下,优选在0~100℃下实施30分钟~48小时即可。The reaction can be carried out at -30 to 150°C, preferably at 0 to 100°C, for 30 minutes to 48 hours.
[制造方法B][Manufacturing method B]
[化学式30][Chemical formula 30]
(式中,R1、R2、R3、R4及X1具有与上述相同的意思)(wherein, R 1 , R 2 , R 3 , R 4 and X 1 have the same meanings as above)
通式[5]所示的化合物或者其盐能够通过对通式[1]所示的化合物或者其盐,使通式[2]所示的化合物或者其盐或者六亚甲基四胺反应之后,根据需要,对得到的化合物或者其盐实施脱保护反应或者水解反应来制造。The compound represented by the general formula [5] or a salt thereof can be produced by reacting the compound represented by the general formula [1] or a salt thereof with the compound represented by the general formula [2] or a salt thereof or hexamethylenetetramine, and then, if necessary, subjecting the obtained compound or salt thereof to a deprotection reaction or a hydrolysis reaction.
(1a)使用氨[2a]的制造方法(1a) Production method using ammonia [2a]
[化学式31][Chemical Formula 31]
(式中,R1及X1具有与上述相同的意思)(wherein, R1 and X1 have the same meanings as above)
通式[5]所示的化合物或者其盐能够通过在碱的存在下或者不存在下,对通式[1]所示的化合物或者其盐使氨[2a]或者其盐反应来制造。The compound represented by the general formula [5] or a salt thereof can be produced by reacting a compound represented by the general formula [1] or a salt thereof with ammonia [2a] or a salt thereof in the presence or absence of a base.
作为该反应所使用的溶剂,只要不对反应造成影响则没有特别限定,但可举出例如,脂肪族烃类、卤化烃类、醚类、酯类、酰胺类、腈类、亚砜类及芳香族烃类,这些溶剂也可以混合使用。The solvent used in the reaction is not particularly limited as long as it does not affect the reaction, and examples thereof include aliphatic hydrocarbons, halogenated hydrocarbons, ethers, esters, amides, nitriles, sulfoxides, and aromatic hydrocarbons. These solvents may also be used as a mixture.
作为优选的溶剂,可举出酰胺类,更优选N,N-二甲基乙酰胺。Preferred solvents include amides, with N,N-dimethylacetamide being more preferred.
溶剂的使用量没有特别限定,但相对于通式[1]所示的化合物或者其盐为1~50倍量(v/w)即可。The amount of the solvent used is not particularly limited, but may be 1 to 50 times (v/w) the amount of the compound represented by the general formula [1] or a salt thereof.
作为氨的盐,可举出例如氯化铵、溴化铵、碘化铵及碳酸铵,优选碘化铵。Examples of ammonia salts include ammonium chloride, ammonium bromide, ammonium iodide, and ammonium carbonate, with ammonium iodide being preferred.
氨或者其盐的使用量相对于通式[1]所示的化合物为1~50倍摩尔,优选1~10倍摩尔即可。The amount of ammonia or a salt thereof used is 1 to 50 times the mole, preferably 1 to 10 times the mole, of the compound represented by the general formula [1].
作为该反应中根据期望所使用的碱,可举出有机碱,优选三乙胺及N,N-二异丙基乙胺。Examples of the base used in this reaction as desired include organic bases, with triethylamine and N,N-diisopropylethylamine being preferred.
碱的使用量相对于通式[1]所示的化合物为1~50倍摩尔,优选1~10倍摩尔即可。The amount of the base used is 1 to 50 times the mole, preferably 1 to 10 times the mole, of the compound represented by the general formula [1].
该反应中可添加盐。作为盐可举出碘化钾等。A salt may be added during this reaction, and examples of the salt include potassium iodide.
盐的使用量相对于通式[1]所示的化合物为0.1~50倍摩尔,优选0.1~10倍摩尔即可。The amount of the salt used is 0.1 to 50 times the mole, preferably 0.1 to 10 times the mole, of the compound represented by the general formula [1].
该反应在-30~150℃下,优选在0~100℃下实施30分钟~48小时即可。The reaction can be carried out at -30 to 150°C, preferably at 0 to 100°C, for 30 minutes to 48 hours.
(1b)通式[2b]所示的化合物或者利用其碱的制造方法(1b) Method for producing a compound represented by general formula [2b] or a base thereof
[化学式32][Chemical Formula 32]
(式中,R1、R2a、R3a及X1具有与上述相同的意思)(wherein, R 1 , R 2a , R 3a and X 1 have the same meanings as above)
作为通式[2b]所示的化合物,已知例如二(叔丁氧基羰基)胺等。As the compound represented by the general formula [2b], for example, di(tert-butoxycarbonyl)amine is known.
通式[3b]所示的化合物或者其盐能够通过在碱的存在下,对通式[1]所示的化合物或者其盐使通式[2b]所示的化合物或者其盐反应来制造。The compound represented by the general formula [3b] or a salt thereof can be produced by reacting the compound represented by the general formula [2b] or a salt thereof with the compound represented by the general formula [1] or a salt thereof in the presence of a base.
作为该反应所使用的溶剂,只要不对反应造成影响则没有特别限定,但可举出例如,脂肪族烃类、卤化烃类、醚类、酯类、酰胺类、腈类、亚砜类及芳香族烃类,这些溶剂也可以混合使用。The solvent used in the reaction is not particularly limited as long as it does not affect the reaction, and examples thereof include aliphatic hydrocarbons, halogenated hydrocarbons, ethers, esters, amides, nitriles, sulfoxides, and aromatic hydrocarbons. These solvents may also be used as a mixture.
作为优选的溶剂,可举出酰胺类,更优选N-甲基吡咯烷酮。Preferred solvents include amides, and N-methylpyrrolidone is more preferred.
溶剂的使用量没有特别限定,但相对于通式[1]所示的化合物或者其盐为1~50倍量(v/w)即可。The amount of the solvent used is not particularly limited, but may be 1 to 50 times (v/w) the amount of the compound represented by the general formula [1] or a salt thereof.
通式[2b]所示的化合物或者其盐的使用量相对于通式[1]所示的化合物或者其盐为1~10倍摩尔,优选1~5倍摩尔即可。The amount of the compound represented by the general formula [2b] or a salt thereof used is 1 to 10 times the mole, preferably 1 to 5 times the mole, of the compound represented by the general formula [1] or a salt thereof.
作为该反应所使用的碱,可举出有机碱及无机碱,优选无机碱,更优选碳酸钾。Examples of the base used in the reaction include organic bases and inorganic bases, among which inorganic bases are preferred, and potassium carbonate is more preferred.
碱的使用量相对于通式[1]所示的化合物为1~50倍摩尔,优选1~10倍摩尔即可。The amount of the base used is 1 to 50 times the mole, preferably 1 to 10 times the mole, of the compound represented by the general formula [1].
该反应中可添加盐。作为盐可举出碘化钾等。A salt may be added during this reaction, and examples of the salt include potassium iodide.
盐的使用量相对于通式[1]所示的化合物为0.1~50倍摩尔,优选0.1~10倍摩尔即可。The amount of the salt used is 0.1 to 50 times the mole, preferably 0.1 to 10 times the mole, of the compound represented by the general formula [1].
该反应在-30~150℃下,优选在0~100℃下实施30分钟~48小时即可。The reaction can be carried out at -30 to 150°C, preferably at 0 to 100°C, for 30 minutes to 48 hours.
通式[5]所示的化合物或者其盐能够通过对通式[3b]所示的化合物或者其盐实施脱保护反应来制造。The compound represented by the general formula [5] or a salt thereof can be produced by subjecting the compound represented by the general formula [3b] or a salt thereof to a deprotection reaction.
该反应能够通过例如有机合成中的保护基(Greene's Protective Groups inOrganic Synthesis)第5版、第895~1193页、2014年、John Wiley&Sons,INC.所记载的方法来进行。This reaction can be carried out, for example, by the method described in Greene's Protective Groups in Organic Synthesis, 5th edition, pp. 895-1193, 2014, John Wiley & Sons, INC.
(1c)使用邻苯二甲酰亚胺钾[2c]的制造方法(1c) Production method using potassium phthalimide [2c]
[化学式33][Chemical Formula 33]
(式中,R1及X1具有与上述相同的意思)(wherein, R1 and X1 have the same meanings as above)
通式[3c]所示的化合物或者其盐能够通过对通式[1]所示的化合物或者其盐使邻苯二甲酰亚胺钾[2c]反应来制造。The compound represented by the general formula [3c] or a salt thereof can be produced by reacting the compound represented by the general formula [1] or a salt thereof with potassium phthalimide [2c].
作为该反应所使用的溶剂,只要不对反应造成影响则没有特别限定,但可举出例如,脂肪族烃类、卤化烃类、醚类、酯类、酰胺类、腈类、亚砜类及芳香族烃类,这些溶剂也可以混合使用。The solvent used in the reaction is not particularly limited as long as it does not affect the reaction, and examples thereof include aliphatic hydrocarbons, halogenated hydrocarbons, ethers, esters, amides, nitriles, sulfoxides, and aromatic hydrocarbons. These solvents may also be used as a mixture.
作为优选的溶剂,可举出亚砜类,更优选二甲基亚砜。Preferred solvents include sulfoxides, with dimethyl sulfoxide being more preferred.
溶剂的使用量没有特别限定,但相对于通式[1]所示的化合物或者其盐为1~50倍量(v/w)即可。The amount of the solvent used is not particularly limited, but may be 1 to 50 times (v/w) the amount of the compound represented by the general formula [1] or a salt thereof.
邻苯二甲酰亚胺钾的使用量相对于通式[1]所示的化合物或者其盐为1~10倍摩尔,优选1~5倍摩尔即可。The amount of potassium phthalimide used is 1 to 10 times the mole, preferably 1 to 5 times the mole, of the compound represented by the general formula [1] or a salt thereof.
邻苯二甲酰亚胺钾例如可使用邻苯二甲酰亚胺及碳酸钾在系统内制备。Potassium phthalimide can be prepared in a system using, for example, phthalimide and potassium carbonate.
优选该反应中添加盐。Preferably, a salt is added to the reaction.
作为盐,可举出碘化钠、碘化钾和碘化锂,优选碘化锂。Examples of the salt include sodium iodide, potassium iodide, and lithium iodide, with lithium iodide being preferred.
盐的使用量相对于通式[1]所示的化合物为0.1~50倍摩尔,优选0.1~10倍摩尔即可。The amount of the salt used is 0.1 to 50 times the mole, preferably 0.1 to 10 times the mole, of the compound represented by the general formula [1].
该反应在-30~150℃下,优选在0~100℃下实施30分钟~48小时即可。The reaction can be carried out at -30 to 150°C, preferably at 0 to 100°C, for 30 minutes to 48 hours.
通式[5]所示的化合物或者其盐能够通过对通式[3c]所示的化合物或者其盐实施脱保护反应来制造。The compound represented by the general formula [5] or a salt thereof can be produced by subjecting the compound represented by the general formula [3c] or a salt thereof to a deprotection reaction.
该反应能够通过例如有机合成中的保护基(Greene's Protective Groups inOrganic Synthesis)第5版、第895~1193页、2014年、John Wiley&Sons,INC.所记载的方法来进行。This reaction can be carried out, for example, by the method described in Greene's Protective Groups in Organic Synthesis, 5th edition, pp. 895-1193, 2014, John Wiley & Sons, INC.
具体而言,可举出使用肼或者乙二胺的方法,优选使用乙二胺的方法。Specifically, there can be mentioned a method using hydrazine or ethylenediamine, and a method using ethylenediamine is preferred.
(1d)使用六亚甲基四胺的制造方法(1d) Production method using hexamethylenetetramine
[化学式34][Chemical Formula 34]
(式中,R4a表示六亚甲基四胺鎓基;R1及X1具有与上述相同的意思)(wherein, R 4a represents a hexamethylenetetraminium group; R 1 and X 1 have the same meanings as above)
通式[3d]所示的化合物或者其盐能够通过对通式[1]所示的化合物或者其盐使六亚甲基四胺反应来制造。The compound represented by the general formula [3d] or a salt thereof can be produced by reacting the compound represented by the general formula [1] or a salt thereof with hexamethylenetetramine.
作为该反应所使用的溶剂,只要不对反应造成影响则没有特别限定,但可举出例如,脂肪族烃类、卤化烃类、醚类、酯类、酰胺类、腈类、亚砜类及芳香族烃类,这些溶剂也可以混合使用。The solvent used in the reaction is not particularly limited as long as it does not affect the reaction, and examples thereof include aliphatic hydrocarbons, halogenated hydrocarbons, ethers, esters, amides, nitriles, sulfoxides, and aromatic hydrocarbons. These solvents may also be used as a mixture.
作为优选的溶剂,可举出酰胺类。Preferred solvents include amides.
溶剂的使用量没有特别限定,但相对于通式[1]所示的化合物为1~50倍量(v/w)即可。The amount of the solvent used is not particularly limited, but may be 1 to 50 times (v/w) the amount of the compound represented by the general formula [1].
六亚甲基四胺的使用量相对于通式[1]所示的化合物为1~10倍摩尔,优选1~5倍摩尔即可。The amount of hexamethylenetetramine used is 1 to 10 times the mole, preferably 1 to 5 times the mole, of the compound represented by the general formula [1].
该反应在-30~150℃下,优选在0~100℃下实施30分钟~48小时即可。The reaction can be carried out at -30 to 150°C, preferably at 0 to 100°C, for 30 minutes to 48 hours.
通式[5]所示的化合物或者其盐能够通过对通式[3d]所示的化合物或者其盐实施基于肼和/或者酸的水解反应来制造。The compound represented by the general formula [5] or a salt thereof can be produced by subjecting the compound represented by the general formula [3d] or a salt thereof to a hydrolysis reaction with hydrazine and/or an acid.
该反应能够通过例如实验化学讲座、第4版、第20卷、第284~292页、1992年、丸善所记载的方法来进行。This reaction can be carried out, for example, by the method described in Experimental Chemistry Kozakō, 4th edition, Vol. 20, pp. 284-292, 1992, Maruzen.
制造方法B中,对通式[1]所示的化合物或者其盐,使R2及R3的至少一个为氨基保护基的通式[2]所示的化合物或者其盐或者六亚甲基四胺反应的情况下,能够对得到的化合物或者其盐实施脱保护反应或者水解反应。In the production method B, when the compound represented by the general formula [1] or its salt is reacted with the compound represented by the general formula [2] wherein at least one of R2 and R3 is an amino-protecting group or its salt, or hexamethylenetetramine, the obtained compound or its salt can be subjected to a deprotection reaction or a hydrolysis reaction.
作为制造方法B,优选制造方法(1a)、制造方法(1b)及制造方法(1c),更优选制造方法(1b),进一步优选R2a为C3-6烷氧羰基,R3a为C3-6烷氧羰基的通式[2b]所示的化合物或者利用其碱的制造方法(1b),尤其优选使用二(叔丁氧基羰基)胺的制造方法(1b)。As the production method B, the production method (1a), the production method (1b) and the production method (1c) are preferred, the production method (1b) is more preferred, and the compound represented by the general formula [2b] wherein R 2a is a C 3-6 alkoxycarbonyl group and R 3a is a C 3-6 alkoxycarbonyl group, or the production method (1b) using a base thereof is further preferred, and the production method (1b) using di(tert-butoxycarbonyl)amine is particularly preferred.
通过使用二(叔丁氧基羰基)胺,能够以高收率、高纯度及简便的操作制造通式[3b]所示的化合物或者其盐。并且,缩短反应时间,可以在更低温度下实施反应。By using di(tert-butoxycarbonyl)amine, the compound represented by the general formula [3b] or a salt thereof can be produced with high yield, high purity, and simple operation. Furthermore, the reaction time is shortened, and the reaction can be carried out at a lower temperature.
并且,通式[3b]所示的化合物或者其盐的体积密度高,且容易处理。Furthermore, the compound represented by the general formula [3b] or a salt thereof has a high bulk density and is easy to handle.
而且,能够通过利用通式[3b]所示的化合物或者其盐,能够以高收率、高纯度及简便的操作制造通式[5]所示的化合物或者其盐。Furthermore, by utilizing the compound represented by the general formula [3b] or a salt thereof, the compound represented by the general formula [5] or a salt thereof can be produced in high yield, high purity, and with a simple operation.
以下示出本发明的制造方法的一例。An example of the production method of the present invention is shown below.
[化学式35][Chemical Formula 35]
另一方面,以下的制造方法记载于专利文献2。On the other hand, the following production method is described in Patent Document 2.
[化学式36][Chemical Formula 36]
本发明的式[C]所示的化合物的盐酸盐为新的化合物。The hydrochloride of the compound represented by formula [C] of the present invention is a novel compound.
式[C]所示的化合物的盐酸盐不需要再结晶,以收率75%、纯度99%来得到。另一方面,专利文献2所记载的制造方法需要再结晶,收率为40%。The hydrochloride of the compound represented by formula [C] was obtained with a yield of 75% and a purity of 99% without requiring recrystallization. On the other hand, the production method described in Patent Document 2 required recrystallization and had a yield of 40%.
本发明的制造方法比专利文献2所记载的制造方法更优异。The production method of the present invention is more excellent than the production method described in Patent Document 2.
式[C]所示的化合物的盐酸盐为有用的化合物。The hydrochloride of the compound represented by formula [C] is a useful compound.
本发明的式[E]所示的化合物为新的化合物。The compound represented by formula [E] of the present invention is a novel compound.
通过代替式[J]所示的化合物,使用式[D]所示的化合物,钯催化剂及碘化铜(I)的使用量大幅减少。其结果,大幅减少式[E]所示的化合物的残留金属量。By using the compound represented by formula [D] instead of the compound represented by formula [J], the amount of palladium catalyst and copper (I) iodide used can be significantly reduced. As a result, the residual metal content of the compound represented by formula [E] can be significantly reduced.
并且,式[D]所示的化合物比式[J]所示的化合物更廉价,且容易取得。Furthermore, the compound represented by formula [D] is cheaper and more readily available than the compound represented by formula [J].
本发明的制造方法比专利文献2所记载的制造方法更优异。The production method of the present invention is more excellent than the production method described in Patent Document 2.
使用式[D]所示的化合物的制造方法为有用。A production method using a compound represented by formula [D] is useful.
式[E]所示的化合物及式[G]所示的化合物为有用的化合物。The compound represented by formula [E] and the compound represented by formula [G] are useful compounds.
[制造方法C][Manufacturing method C]
[化学式37][Chemical Formula 37]
(式中,R1、R5、R6、R7、X4及X5具有与上述相同的意思)(wherein, R 1 , R 5 , R 6 , R 7 , X 4 and X 5 have the same meanings as above)
<第1工序><Step 1>
(1a)X4为羟基的情况(1a) When X 4 is a hydroxyl group
作为通式[9]所示的化合物,已知例如,N-(叔丁氧基羰基)-N-甲基-L-丙氨酸。As a compound represented by the general formula [9], for example, N-(tert-butoxycarbonyl)-N-methyl-L-alanine is known.
通式[10]所示的化合物或者其盐能够通过在冷凝剂或者酸卤化物的存在下、碱的存在下,对通式[5]所示的化合物或者其盐使通式[9]所示的化合物或者其盐反应来制造。The compound represented by the general formula [10] or a salt thereof can be produced by reacting the compound represented by the general formula [9] or a salt thereof with the compound represented by the general formula [5] or a salt thereof in the presence of a condensing agent or an acid halide and in the presence of a base.
该反应能够通过例如化学评论(Chemical Reviews)、第97卷、2243页、1997年、天然产物的化学合成肽:非编码氨基酸Inz肽的键合方法(Chemical Synthesis of NaturalProduct Peptides:Coupling Methods for the Incorporation of Noncoded AminoAcids into Peptides)或者四面体(Tetr ahedron)2004年、第60卷、2447页、(Recentdevelopment of peptide coupling reagents in organic synthesis)所记载的方法来进行。This reaction can be carried out by, for example, the method described in Chemical Reviews, Vol. 97, p. 2243, 1997, Chemical Synthesis of Natural Product Peptides: Coupling Methods for the Incorporation of Noncoded Amino Acids into Peptides, or Tetrahedron, Vol. 60, p. 2447, 2004, (Recent development of peptide coupling reagents in organic synthesis).
作为该反应所使用的溶剂,只要不对反应造成影响则没有特别限定,但可举出例如,卤化烃类、醚类、酯类、酰胺类、腈类、亚砜类及芳香族烃类,这些溶剂也可以混合使用。The solvent used in the reaction is not particularly limited as long as it does not affect the reaction, and examples thereof include halogenated hydrocarbons, ethers, esters, amides, nitriles, sulfoxides, and aromatic hydrocarbons. These solvents may also be used as a mixture.
作为优选的溶剂,可举出酰胺类,更优选N,N-二甲基甲酰胺或者N-甲基吡咯烷酮。Preferred solvents include amides, with N,N-dimethylformamide or N-methylpyrrolidone being more preferred.
溶剂的使用量没有特别限定,但相对于通式[5]所示的化合物或者其盐为1~500倍量(v/w)即可。The amount of the solvent used is not particularly limited, but may be 1 to 500 times (v/w) the amount of the compound represented by the general formula [5] or a salt thereof.
作为该反应所使用的碱,可举出无机碱或者有机碱。Examples of the base used in this reaction include inorganic bases and organic bases.
作为优选的碱,可举出有机碱,更优选三乙胺、N,N-二异丙基乙胺及4-甲基吗啉,进一步优选N,N-二异丙基乙胺及4-甲基吗啉。Preferred bases include organic bases, more preferably triethylamine, N,N-diisopropylethylamine, and 4-methylmorpholine, and even more preferably N,N-diisopropylethylamine and 4-methylmorpholine.
碱的使用量相对于通式[5]所示的化合物或者其盐为1~50倍摩尔,优选1~10倍摩尔即可。The amount of the base used is 1 to 50 times the mole, preferably 1 to 10 times the mole, of the compound represented by the general formula [5] or a salt thereof.
作为该反应所使用的冷凝剂,可举出例如,N,N'-二异丙基碳二亚胺(DIC)、N,N’-二(锡基)碳二亚胺、N,N’-二环己基碳二亚胺(DCC)、N-(叔丁基)-N'-乙基碳二亚胺(BEC)、N-环己基-N'-(2-吗啉代乙基)碳二亚胺(CMC)及1-乙基-3-(3-二甲基氨基丙基)碳二亚胺(EDC)等碳化二亚胺类;1,1'-羰基二咪唑(CDI)及1,1'-羰基二(1,2,4-三唑)(CDT)等咪唑鎓类;二苯基磷酰基叠氮化物等酸叠氮化物类;二乙基磷酰氰等酸性氰化物类;2-乙氧基-1-乙氧羰基-1,2-二氢喹啉;O-(苯并三唑-1-基)-N,N,N’,N’-四甲基脲六氟磷酸盐(HBTU)、O-(7-氮杂苯并三唑-1-基)-N,N,N’,N'-四甲基脲六氟磷酸盐(HATU)、O-(苯并三唑-1-基)-N,N,N’,N’-双(四亚甲基)六氟磷酸尿苷(HBPyU)、O-(苯并三唑-1-基)-N,N,N’,N’-双(五亚甲基)脲六氟磷酸盐(HBPipU)、O-(6-氯苯并三唑-1-基)-N,N,N’,N’-四甲基脲六氟磷酸盐(HCTU)、O-(3,4-二氢-4-氧代-1,2,3-苯并三嗪-3-基)-N,N,N’,N’-四甲基脲六氟磷酸盐(HDBTU)、O-(2-氧代-1(2H)吡啶基)-N,N,N’,N’-四甲基脲六氟磷酸盐(TPTU)、O-((乙氧基羰基)氰基亚甲基氨基)-N,N,N’,N’-四甲基脲六氟磷酸盐(HOTU)、O-((乙氧基羰基)氰基亚甲基氨基)-N,N,N’,N’-四甲基脲四氟硼酸盐(TOTU)、N,N,N’,N’-四甲基-O-(N-琥珀酰亚胺基)六氟磷酸尿苷(HSTU)、N,N,N’,N’-四甲基-O-(N-琥珀酰亚胺基)尿酸四氟硼酸盐(TSTU)二吡咯烷(N-琥珀酰亚胺基氧基)碳鎓六氟磷酸盐(HSPyU)及S-(1-氧化物-2-吡啶基)-N,N,N’,N’-四甲基硫脲四氟硼酸盐(TOTT)等脲化合物类。Examples of the condensing agent used in the reaction include carbodiimides such as N,N'-diisopropylcarbodiimide (DIC), N,N'-di(tinyl)carbodiimide, N,N'-dicyclohexylcarbodiimide (DCC), N-(tert-butyl)-N'-ethylcarbodiimide (BEC), N-cyclohexyl-N'-(2-morpholinoethyl)carbodiimide (CMC), and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC); imidazoliums such as 1,1'-carbonyldiimidazole (CDI) and 1,1'-carbonylbis(1,2,4-triazole) (CDT); and diphenylmethane. Acid azides such as 1,2-diethylphosphoryl azide; acid cyanides such as diethylphosphoryl cyanide; 2-ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline; O-(benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HBTU), O-(7-azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HATU), O-(benzotriazol-1-yl)-N,N,N’,N’-bis(tetramethylene)uridine hexafluorophosphate (HBPyU), O-(benzotriazol-1-yl)-N,N,N’,N’-bis(pentamethylene)uridine hexafluorophosphate hexafluorophosphate (HBPipU), O-(6-chlorobenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HCTU), O-(3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HDBTU), O-(2-oxo-1(2H)pyridinyl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (TPTU), O-((ethoxycarbonyl)cyanomethyleneamino)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HOTU ), O-((ethoxycarbonyl)cyanomethyleneamino)-N,N,N’,N’-tetramethyluronium tetrafluoroborate (TOTU), N,N,N’,N’-tetramethyl-O-(N-succinimidyl)uridine hexafluorophosphate (HSTU), N,N,N’,N’-tetramethyl-O-(N-succinimidyl)uric acid tetrafluoroborate (TSTU), dipyrrolidine (N-succinimidyloxy)carbonium hexafluorophosphate (HSPyU) and S-(1-oxide-2-pyridyl)-N,N,N’,N’-tetramethylthiourea tetrafluoroborate (TOTT) and other urea compounds.
作为优选的冷凝剂,可举出碳二亚胺类,更优选EDC。Preferred condensing agents include carbodiimides, and EDC is more preferred.
冷凝剂的使用量相对于通式[5]所示的化合物或者其盐为1~50倍摩尔,优选1~5倍摩尔即可。The amount of the condensing agent used is 1 to 50 times the mole of the compound represented by the general formula [5] or its salt, and preferably 1 to 5 times the mole.
作为冷凝剂使用碳二亚胺类的情况下,优选加入添加剂。When carbodiimides are used as the condensing agent, it is preferable to add an additive.
作为添加剂,可举出例如,1-羟基苯并三唑(HOBT)、1-羟基-7-氮杂苯并三唑(HOAT)及乙基(羟基亚氨基)氰基乙酸酯,优选HOBT及乙基(羟基亚氨基)氰基乙酸酯。Examples of the additive include 1-hydroxybenzotriazole (HOBT), 1-hydroxy-7-azabenzotriazole (HOAT), and ethyl (hydroxyimino)cyanoacetate, with HOBT and ethyl (hydroxyimino)cyanoacetate being preferred.
添加剂的使用量相对于通式[5]所示的化合物或者其盐为0.01~10倍摩尔,优选0.1~1倍摩尔即可。The amount of the additive used is 0.01 to 10 times the mole, preferably 0.1 to 1 times the mole, of the compound represented by the general formula [5] or a salt thereof.
作为该反应所使用的酸卤化物,可举出例如,乙酰氯及三氟乙酰等羧酸卤化物类;甲磺酰氯及甲苯磺酰氯等磺酸卤化物类;氯甲酸乙酯及氯甲酸异丁酯等氯仿酸酯类。Examples of the acid halide used in the reaction include carboxylic acid halides such as acetyl chloride and trifluoroacetyl; sulfonic acid halides such as methanesulfonyl chloride and toluenesulfonyl chloride; and chloroformic acid esters such as ethyl chloroformate and isobutyl chloroformate.
通式[9]所示的化合物或者其盐的使用量没有特别限定,但相对于通式[5]所示的化合物或者其盐为1~10倍摩尔即可。The amount of the compound represented by the general formula [9] or its salt used is not particularly limited, but may be 1 to 10 times the molar amount of the compound represented by the general formula [5] or its salt.
该反应在-30~150℃下,优选在0~100℃下实施30分钟~48小时即可。The reaction can be carried out at -30 to 150°C, preferably at 0 to 100°C, for 30 minutes to 48 hours.
(1b)X4为离去基的情况下,(1b) When X 4 is a leaving group,
通式[10]所示的化合物或者其盐能够通过在碱的存在下,对通式[5]所示的化合物或者其盐使通式[9]所示的化合物反应来制造。The compound represented by the general formula [10] or a salt thereof can be produced by reacting the compound represented by the general formula [9] with the compound represented by the general formula [5] or a salt thereof in the presence of a base.
作为该反应所使用的溶剂,只要不对反应造成影响则没有特别限定,但可举出例如,卤化烃类、醚类、酯类、酰胺类、腈类及芳香族烃类,这些溶剂也可以混合使用。The solvent used in the reaction is not particularly limited as long as it does not affect the reaction, and examples thereof include halogenated hydrocarbons, ethers, esters, amides, nitriles, and aromatic hydrocarbons. These solvents may also be used as a mixture.
溶剂的使用量没有特别限定,但相对于通式[5]所示的化合物或者其盐为1~500倍量(v/w)即可。The amount of the solvent used is not particularly limited, but may be 1 to 500 times (v/w) the amount of the compound represented by the general formula [5] or a salt thereof.
作为该反应所使用的碱,可举出无机碱或者有机碱。Examples of the base used in this reaction include inorganic bases and organic bases.
碱的使用量相对于通式[5]所示的化合物或者其盐,为1~50倍摩尔,优选1~5倍摩尔即可。The amount of the base used is 1 to 50 times the mole, preferably 1 to 5 times the mole, of the compound represented by the general formula [5] or a salt thereof.
通式[9]所示的化合物或者其盐的使用量没有特别限定,但相对于通式[5]所示的化合物或者其盐为1~10倍摩尔即可。The amount of the compound represented by the general formula [9] or its salt used is not particularly limited, but may be 1 to 10 times the molar amount of the compound represented by the general formula [5] or its salt.
该反应在-30~150℃下,优选在0~100℃下实施30分钟~48小时即可。The reaction can be carried out at -30 to 150°C, preferably at 0 to 100°C, for 30 minutes to 48 hours.
作为第1工序,优选制造方法(1a),更优选使用N-(叔丁氧基羰基)-N-甲基-L-丙氨酸的制造方法。As the first step, the production method (1a) is preferred, and a production method using N-(tert-butoxycarbonyl)-N-methyl-L-alanine is more preferred.
<第2工序><Step 2>
通式[11]所示的化合物或者其盐能够通过将通式[10]所示的化合物或者其盐进行脱保护来制造。The compound represented by the general formula [11] or a salt thereof can be produced by deprotecting the compound represented by the general formula [10] or a salt thereof.
该反应能够通过例如有机合成中的保护基(Greene's Protective Groups inOrganic Synthesis)第5版、第895~1193页、2014年、John Wiley&Sons,INC.所记载的方法来进行。This reaction can be carried out, for example, by the method described in Greene's Protective Groups in Organic Synthesis, 5th edition, pp. 895-1193, 2014, John Wiley & Sons, INC.
<第3工序><Step 3>
通式[13]所示的化合物或者其盐能够通过在碱的存在下、冷凝剂或者酸卤化物的存在下,使通式[11]所示的化合物或者其盐与通式[12]所示的化合物或者其盐反应来制造。The compound represented by the general formula [13] or a salt thereof can be produced by reacting the compound represented by the general formula [11] or a salt thereof with the compound represented by the general formula [12] or a salt thereof in the presence of a base, a condensing agent or an acid halide.
该反应按照制造方法C<第1工序>进行即可。This reaction may be carried out according to Production Method C <Step 1>.
在上述的制造方法中使用的化合物中,存在溶剂化物、水合物及各种形态的晶体的情况下,还能够使用这些溶剂化物、水合物及各种形态的晶体。When the compound used in the above-mentioned production method exists in the form of a solvate, a hydrate, or various forms of crystals, these solvates, hydrates, or various forms of crystals can also be used.
在上述的制造方法中使用的化合物中,例如,具有氨基、羟基或者羧基等的化合物通过通常的保护基预先保护这些基团,反应后,能够通过自身公知的方法脱离这些保护基。Among the compounds used in the above-mentioned production methods, compounds having amino, hydroxyl or carboxyl groups, for example, are protected in advance with common protecting groups, and these protecting groups can be removed by known methods after the reaction.
通过上述的制造方法得到的化合物通过实施例如,缩合、加聚、氧化、还原、位错、取代、卤化、脱水或者水解等自身公知的反应,或者通过适当组合这些反应,能够衍生其它的化合物。The compound obtained by the above-mentioned production method can be derived into other compounds by subjecting the compound to known reactions such as condensation, polyaddition, oxidation, reduction, dislocation, substitution, halogenation, dehydration or hydrolysis, or by appropriately combining these reactions.
[实施例][Example]
以下,举出参考例及实施例来说明本发明,但本发明并非限定于此。Hereinafter, the present invention will be described with reference to reference examples and examples, but the present invention is not limited thereto.
硅胶柱层析中的载体使用硅胶60(球状)(KANTO CHEMICAL CO.,INC.)。Silica gel 60 (spherical) (KANTO CHEMICAL CO., INC.) was used as a support in silica gel column chromatography.
洗脱液中的混合比为容量比。The mixing ratio in the eluent is the volume ratio.
1H-核磁共振光谱使用四甲基硅烷作为内部基准,使用JNM-AL400(JEOL Ltd.,)进行测定。 1 H-NMR spectra were measured using JNM-AL400 (JEOL Ltd.) using tetramethylsilane as an internal standard.
质谱使用LCMS-2020(SHIMADZU CORPORATION)来进行测定。Mass spectrometry was measured using LCMS-2020 (SHIMADZU CORPORATION).
以下的缩写具有以下的意思。The following abbreviations have the following meanings.
Boc:叔丁氧羰基Boc: tert-butyloxycarbonyl
Ms:甲磺酰基Ms:Methylsulfonyl
Pr:丙基Pr: Propyl
参考例1Reference Example 1
[化学式38][Chemical Formula 38]
在冰冷下将丙胺3.55mL加入按照WO2008/155140A1所记载的方法合成的2,4-二氯-5-碘嘧啶5.77g及N,N-二异丙基乙胺7.86mL的四氢呋喃83mL溶液中,在室温下搅拌1小时。反应混合物中加入水及乙酸乙酯。分离出有机层,并以乙酸乙酯提取水层。合并有机层及提取液,以1.0mol/L盐酸水溶液、水、饱和碳酸氢钠水溶液及饱和氯化钠水溶液依次清洗后,以无水硫酸镁使其干燥,在减压下蒸馏除去溶剂,获得油状的2-氯-5-碘-N-丙基嘧啶-4-胺6.44g。Under ice-cooling, 3.55 mL of propylamine was added to a solution of 5.77 g of 2,4-dichloro-5-iodopyrimidine (synthesized according to the method described in WO2008/155140A1) and 7.86 mL of N,N-diisopropylethylamine in 83 mL of tetrahydrofuran. The mixture was stirred at room temperature for 1 hour. Water and ethyl acetate were added to the reaction mixture. The organic layer was separated, and the aqueous layer was extracted with ethyl acetate. The organic layer and the extract were combined and washed sequentially with 1.0 mol/L aqueous hydrochloric acid, water, saturated aqueous sodium bicarbonate, and saturated aqueous sodium chloride. The mixture was then dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain 6.44 g of 2-chloro-5-iodo-N-propylpyrimidin-4-amine as an oil.
MS m/z(M+H):298.3MS m/z(M+H):298.3
参考例2Reference Example 2
[化学式39][Chemical Formula 39]
在氮气气氛下,将三乙胺11.0g、二(三苯基膦)二氯化钯(II)0.17g及碘化铜(I)0.23g加入到N2-(4-氰基苯基)-5-碘-N4-丙基嘧啶-2,4-二胺盐酸盐5.00g的四氢呋喃35mL悬浮液中,在40~45℃加入4-戊炔-1-醇1.32g之后,在相同温度下搅拌4小时30分钟。将反应混合物冷却至30℃,加入15%氯化铵水溶液25mL。分离出有机层,以15%氯化铵水溶液清洗之后,加入N-乙酰-L-半胱氨酸0.25g,在20~30℃下搅拌30分钟。将四氢呋喃7.5mL及甲醇50mL加入到反应混合物中,在20~30℃下搅拌30分钟。将水50mL加入到反应混合物中,在20~30℃下搅拌30分钟之后,在0~10℃下搅拌1小时。过滤出固体物质,获得淡黄色固体的4-((5-(5-羟基-1-戊炔-1-基)-4-(丙基氨基)嘧啶-2-基)氨基)苄腈3.06g。Under a nitrogen atmosphere, 11.0 g of triethylamine, 0.17 g of bis(triphenylphosphine)palladium(II) dichloride, and 0.23 g of copper(I) iodide were added to a suspension of 5.00 g of N 2 -(4-cyanophenyl)-5-iodo- N 4 -propylpyrimidine-2,4-diamine hydrochloride in 35 mL of tetrahydrofuran. 1.32 g of 4-pentyn-1-ol was added at 40-45°C, and the mixture was stirred at the same temperature for 4 hours and 30 minutes. The reaction mixture was cooled to 30°C, and 25 mL of a 15% aqueous ammonium chloride solution was added. The organic layer was separated and washed with a 15% aqueous ammonium chloride solution. 0.25 g of N-acetyl-L-cysteine was added, and the mixture was stirred at 20-30°C for 30 minutes. 7.5 mL of tetrahydrofuran and 50 mL of methanol were added to the reaction mixture, and the mixture was stirred at 20-30°C for 30 minutes. 50 mL of water was added to the reaction mixture, and the mixture was stirred at 20-30°C for 30 minutes, and then at 0-10°C for 1 hour. The solid substance was filtered to obtain 3.06 g of 4-((5-(5-hydroxy-1-pentyn-1-yl)-4-(propylamino)pyrimidin-2-yl)amino)benzonitrile as a pale yellow solid.
1H-NMR(CDCl3)δ:8.00(1H,s),7.75(2H,d,J=8.8Hz),7.57(2H,d,J=8.8Hz),7.17(1H,brs),5.69(2H,t,J=5.2Hz),3.84(2H,t,J=5.8Hz),3.50-3.42(2H,m),2.62(2H,t,J=7.0Hz),1.93-1.84(2H,m),1.75-1.64(2H,m),1.02(3H,t,J=7.6Hz). 1 H-NMR (CDCl 3 )δ: 8.00 (1H, s), 7.75 (2H, d, J = 8.8Hz), 7.57 (2H, d, J = 8.8Hz), 7.17 (1H, brs), 5.69 (2H, t, J = 5.2Hz), 3.84 (2H, t, J=5.8Hz),3.50-3.42(2H,m),2.62(2H,t,J=7.0Hz),1.93-1.84(2H,m),1.75-1.64(2H,m),1.02(3H,t,J=7.6Hz).
实施例1Example 1
[化学式40][Chemical Formula 40]
在室温将4-氨基苄腈49.6g及盐酸36mL加入到2-氯-5-碘-N-丙基嘧啶-4-胺31.3g的N-甲基吡咯烷酮125mL溶液中,在50~60℃下搅拌5小时。将反应混合物冷却至30℃之后,加入甲醇250mL,在30℃下搅拌30分钟。将水250mL加入到反应混合物中,在28℃下搅拌1小时。过滤出固体物质,获得淡黄色固体的N2-(4-氰基苯基)-5-碘-N4-丙基嘧啶-2,4-二胺盐酸盐32.9g。49.6 g of 4-aminobenzonitrile and 36 mL of hydrochloric acid were added to a solution of 31.3 g of 2-chloro-5-iodo-N-propylpyrimidin-4-amine in 125 mL of N-methylpyrrolidone at room temperature and stirred at 50-60°C for 5 hours. After cooling the reaction mixture to 30°C, 250 mL of methanol was added and the mixture was stirred at 30°C for 30 minutes. 250 mL of water was added to the reaction mixture and stirred at 28°C for 1 hour. The solid was filtered to obtain 32.9 g of N 2 -(4-cyanophenyl)-5-iodo-N 4 -propylpyrimidine-2,4-diamine hydrochloride as a light yellow solid.
1H-NMR(DMSO-d6)δ:10.28(1H,brs),8.25(1H,s),7.87(2H,d,J=8.8Hz),7.76(2H,d,J=8.8Hz),7.56(1H,brs),3.38(2H,dd,J=6.0,14.3Hz),1.65-1.53(2H,m),0.90(3H,t,J=7.4Hz). 1 H-NMR (DMSO-d 6 )δ: 10.28(1H,brs),8.25(1H,s),7.87(2H,d,J=8.8Hz),7.76(2H,d,J=8.8Hz),7.5 6(1H,brs),3.38(2H,dd,J=6.0,14.3Hz),1.65-1.53(2H,m),0.90(3H,t,J=7.4Hz).
实施例2Example 2
[化学式41][Chemical Formula 41]
在10℃将三乙胺0.23g及甲磺酰氯0.20g加入到4-((5-(5-羟基-1-戊炔-1-基)-4-(丙基氨基)嘧啶-2-基)氨基)苄腈0.50g的氯仿5.0mL悬浮液中,在0~10℃下搅拌3小时。将三乙胺0.06g及甲磺酰氯0.05g加入到反应混合物中,在0~10℃下搅拌3小时。将三乙胺0.06g及甲磺酰氯0.05g加入到反应混合物中,在0~10℃下搅拌1小时。将水及氯仿加入到反应混合物中。分离出有机层,以无水硫酸镁使其干燥之后,在减压下蒸馏除去溶剂,获得淡黄色固体的(5-(2-(4-氰基苯胺基)-4-(丙基氨基)嘧啶-5-基)-4-戊烯-1-基)甲磺酸盐0.62g。0.23 g of triethylamine and 0.20 g of methanesulfonyl chloride were added to a suspension of 0.50 g of 4-((5-(5-hydroxy-1-pentyn-1-yl)-4-(propylamino)pyrimidin-2-yl)amino)benzonitrile in 5.0 mL of chloroform at 10°C, and the mixture was stirred at 0-10°C for 3 hours. 0.06 g of triethylamine and 0.05 g of methanesulfonyl chloride were added to the reaction mixture, and the mixture was stirred at 0-10°C for 3 hours. 0.06 g of triethylamine and 0.05 g of methanesulfonyl chloride were added to the reaction mixture, and the mixture was stirred at 0-10°C for 1 hour. Water and chloroform were added to the reaction mixture. The organic layer was separated and dried over anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure to obtain 0.62 g of (5-(2-(4-cyanoanilino)-4-(propylamino)pyrimidin-5-yl)-4-penten-1-yl)methanesulfonate as a pale yellow solid.
1H-NMR(CDCl3)δ:7.98(1H,s),7.76(2H,d,J=9.2Hz),7.57(2H,d,J=9.2Hz),7.54(1H,brs),5.86(2H,t,J=5.2Hz),4.44(2H,t,J=5.6Hz),3.51-3.42(2H,m),3.06(3H,s),2.68(2H,t,J=6.6Hz),2.08-2.00(2H,m),1.74-1.65(2H,m),1.01(3H,t,J=7.4Hz). 1 H-NMR (CDCl 3 )δ: 7.98 (1H, s), 7.76 (2H, d, J = 9.2Hz), 7.57 (2H, d, J = 9.2Hz), 7.54 (1H, brs), 5.86 (2H, t, J = 5.2Hz), 4.44 (2H, t, J = 5.6H z),3.51-3.42(2H,m),3.06(3H,s),2.68(2H,t,J=6.6Hz),2.08-2.00(2H,m),1.74-1.65(2H,m),1.01(3H,t,J=7.4Hz).
实施例3Example 3
[化学式42][Chemical Formula 42]
将亚硫酰氯0.53g加入到4-((5-(5-羟基-1-戊炔-1-基)-4-(丙基氨基)嘧啶-2-基)氨基)苄腈0.50g的甲苯5.0mL悬浮液中,在80℃下搅拌3小时。将反应混合物冷却至20℃之后,加入四氢呋喃及5%碳酸氢钠水溶液。分离出有机层,以无水硫酸镁使其干燥之后,在减压下蒸馏除去溶剂,获得黄褐色固体的4-((5-(5-氯-1-戊炔-1-基)-4-(丙基氨基)嘧啶-2-基)氨基)苄腈0.47g。0.53 g of thionyl chloride was added to a 5.0 mL suspension of 0.50 g of 4-((5-(5-hydroxy-1-pentyn-1-yl)-4-(propylamino)pyrimidin-2-yl)amino)benzonitrile in toluene, and the mixture was stirred at 80°C for 3 hours. After the reaction mixture was cooled to 20°C, tetrahydrofuran and a 5% aqueous sodium bicarbonate solution were added. The organic layer was separated and dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure to obtain 0.47 g of 4-((5-(5-chloro-1-pentyn-1-yl)-4-(propylamino)pyrimidin-2-yl)amino)benzonitrile as a yellowish-brown solid.
1H-NMR(CDCl3)δ:8.01(1H,s),7.75(2H,d,J=9.0Hz),7.57(2H,d,J=9.0Hz),7.25(1H,brs),5.58(2H,t,J=5.4Hz),3.72(2H,t,J=6.2Hz),3.52-3.42(2H,m),2.70(2H,t,J=6.8Hz),2.12-2.03(2H,m),1.76-1.65(2H,m),1.02(3H,t,J=7.4Hz). 1 H-NMR (CDCl 3 )δ: 8.01 (1H, s), 7.75 (2H, d, J = 9.0Hz), 7.57 (2H, d, J = 9.0Hz), 7.25 (1H, brs), 5.58 (2H, t, J = 5.4Hz), 3.72 (2H, t, J=6.2Hz),3.52-3.42(2H,m),2.70(2H,t,J=6.8Hz),2.12-2.03(2H,m),1.76-1.65(2H,m),1.02(3H,t,J=7.4Hz).
实施例4Example 4
[化学式43][Chemical Formula 43]
在氮气气氛下将三乙胺132g、二(三苯基膦)二氯化钯(II)2.0g及碘化铜(I)2.8g加入到N2-(4-氰基苯基)-5-碘-N4-丙基嘧啶-2,4-二胺盐酸盐60.0g的四氢呋喃480mL悬浮液中,在30℃加入5-氯-1-戊炔19.3g之后,在相同温度下搅拌1小时。将反应混合物冷却至25℃,加入三丁基膦30mL,在20~30℃下搅拌2小时。将15%氯化铵水溶液300mL加入到反应混合物。分离出有机层,以15%氯化铵水溶液300mL清洗2次之后,加入甲醇600mL,在20~30℃下搅拌1小时。将水300mL加入到反应混合物,在20~30℃下搅拌30分钟,在0~10℃下搅拌1小时。过滤出固体物质,获得淡黄色固体的4-((5-(5-氯-1-戊炔-1-基)-4-(丙基氨基)嘧啶-2-基)氨基)苄腈45.8g。Under a nitrogen atmosphere, 132 g of triethylamine, 2.0 g of bis(triphenylphosphine)palladium(II) dichloride, and 2.8 g of copper(I) iodide were added to a suspension of 60.0 g of N 2 -(4-cyanophenyl)-5-iodo- N 4 -propylpyrimidine-2,4-diamine hydrochloride in 480 mL of tetrahydrofuran. 19.3 g of 5-chloro-1-pentyne was added at 30°C, and the mixture was stirred at the same temperature for 1 hour. The reaction mixture was cooled to 25°C, 30 mL of tributylphosphine was added, and the mixture was stirred at 20-30°C for 2 hours. 300 mL of 15% aqueous ammonium chloride solution was added to the reaction mixture. The organic layer was separated, washed twice with 300 mL of 15% aqueous ammonium chloride solution, and then 600 mL of methanol was added, followed by stirring at 20-30°C for 1 hour. 300 mL of water was added to the reaction mixture, and the mixture was stirred at 20-30°C for 30 minutes and then at 0-10°C for 1 hour. The solid substance was filtered off to obtain 45.8 g of 4-((5-(5-chloro-1-pentyn-1-yl)-4-(propylamino)pyrimidin-2-yl)amino)benzonitrile as a light yellow solid.
测定残留金属量的结果,钯为50ppm以下,铜为50ppm以下。The amount of residual metals was measured and found to be 50 ppm or less of palladium and 50 ppm or less of copper.
1H-NMR(DMSO-d6)δ:9.80(1H,s),8.01(1H,s),7.96(2H,d,J=8.8Hz),7.68(2H,d,J=8.8Hz),6.94(1H,t,J=6.5Hz),3.77(2H,t,J=6.5Hz),3.43-3.35(2H,m),2.62(2H,t,J=7.1Hz),2.07-1.98(2H,m),1.67-1.54(2H,m),0.92(3H,t,J=7.5Hz). 1 H-NMR (DMSO-d 6 )δ: 9.80(1H,s),8.01(1H,s),7.96(2H,d,J=8.8Hz),7.68(2H,d,J=8.8Hz),6.94(1H,t,J=6.5Hz),3.77(2H,t,J =6.5Hz),3.43-3.35(2H,m),2.62(2H,t,J=7.1Hz),2.07-1.98(2H,m),1.67-1.54(2H,m),0.92(3H,t,J=7.5Hz).
实施例5Example 5
[化学式44][Chemical Formula 44]
将N,N-二异丙基乙胺2.5mL及碘化铵2.05g加入到4-((5-(5-氯-1-戊炔-1-基)-4-(丙基氨基)嘧啶-2-基)氨基)苄腈0.50g的N,N-二甲基乙酰胺5.0mL悬浮液中,在50℃下搅拌27小时。将反应混合物冷却至室温之后,加入乙酸乙酯20mL及水40mL。过滤出固体物质,加入2-丁酮20mL及水20mL,以25%氢氧化钠水溶液调整为pH13.5。分离出有机层,在减压下蒸馏除去溶剂。将得到的残留物以硅胶柱层析(洗脱液:氯仿/甲醇=5/1→3/1→2/1)进行精制,获得淡黄色固体的4-((5-(5-氨基-1-戊炔-1-基)-4-(丙基氨基)嘧啶-2-基)氨基)苄腈0.11g。2.5 mL of N,N-diisopropylethylamine and 2.05 g of ammonium iodide were added to a suspension of 0.50 g of 4-((5-(5-chloro-1-pentyn-1-yl)-4-(propylamino)pyrimidin-2-yl)amino)benzonitrile in 5.0 mL of N,N-dimethylacetamide and stirred at 50°C for 27 hours. After the reaction mixture was cooled to room temperature, 20 mL of ethyl acetate and 40 mL of water were added. The solids were filtered, 20 mL of 2-butanone and 20 mL of water were added, and the pH was adjusted to 13.5 with 25% aqueous sodium hydroxide solution. The organic layer was separated, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (eluent: chloroform/methanol = 5/1→3/1→2/1) to obtain 0.11 g of 4-((5-(5-amino-1-pentyn-1-yl)-4-(propylamino)pyrimidin-2-yl)amino)benzonitrile as a pale yellow solid.
1H-NMR(DMSO-d6)δ:9.78(1H,s),7.97(1H,s),7.96(2H,d,J=8.6Hz),7.68(2H,d,J=8.6Hz),7.09-6.99(1H,m),3.42-3.27(2H,m),2.67(2H,d,J=6.6Hz),2.54-2.47(2H,m),1.72-1.54(4H,m),0.92(3H,t,J=7.4Hz). 1 H-NMR (DMSO-d 6 )δ: 9.78(1H,s),7.97(1H,s),7.96(2H,d,J=8.6Hz),7.68(2H,d,J=8.6Hz),7.09-6.99(1H,m),3.4 2-3.27(2H,m),2.67(2H,d,J=6.6Hz),2.54-2.47(2H,m),1.72-1.54(4H,m),0.92(3H,t,J=7.4Hz).
实施例6Example 6
[化学式45][Chemical Formula 45]
将4-((5-(5-氯-1-戊炔-1-基)-4-(丙基氨基)嘧啶-2-基)氨基)苄腈45.0g、二(叔丁氧基羰基)胺41.4g及碳酸钾70.3g的N-甲基-2-吡咯烷酮135mL悬浮液在70℃下搅拌6小时15分钟。将反应混合物冷却至室温之后,静置一晩。将反应混合物加热至55℃,加入2-丁酮315mL及水180mL。分离出有机层,以10%氯化钠水溶液清洗之后,冷却至40℃,在35~40℃下搅拌2小时。将反应混合物冷却至25℃之后,加入50%甲醇水溶液315mL,在15~25℃下搅拌3小时30分钟。过滤出固体物质,获得叔丁基-N-(叔丁氧基羰基)-N-(5-(2-(4-氰基苯胺基)-4-(丙基氨基)嘧啶-5-基)-4-戊烯-1-基)氨基甲酸酯63.5g。A suspension of 45.0 g of 4-((5-(5-chloro-1-pentyn-1-yl)-4-(propylamino)pyrimidin-2-yl)amino)benzonitrile, 41.4 g of di(tert-butoxycarbonyl)amine, and 70.3 g of potassium carbonate in 135 mL of N-methyl-2-pyrrolidone was stirred at 70°C for 6 hours and 15 minutes. The reaction mixture was cooled to room temperature and allowed to stand overnight. The reaction mixture was heated to 55°C, and 315 mL of 2-butanone and 180 mL of water were added. The organic layer was separated, washed with a 10% aqueous sodium chloride solution, cooled to 40°C, and stirred at 35-40°C for 2 hours. After the reaction mixture was cooled to 25°C, 315 mL of a 50% aqueous methanol solution was added, and the mixture was stirred at 15-25°C for 3 hours and 30 minutes. The solid substance was filtered to obtain 63.5 g of tert-butyl-N-(tert-butoxycarbonyl)-N-(5-(2-(4-cyanoanilino)-4-(propylamino)pyrimidin-5-yl)-4-penten-1-yl)carbamate.
1H-NMR(DMSO-d6)δ:9.80(1H,s),8.00(1H,s),7.96(2H,d,J=8.6Hz),7.68(2H,d,J=8.6Hz),6.94(1H,t,J=6.0Hz),3.65(2H,t,J=7.1Hz),3.45-3.36(2H,m),2.49-2.44(2H,m),1.83-1.73(2H,m),1.67-1.56(2H,m),1.45(18H,s),0.92(3H,t,J=7.3Hz). 1 H-NMR (DMSO-d 6 )δ: 9.80(1H,s),8.00(1H,s),7.96(2H,d,J=8.6Hz),7.68(2H,d,J=8.6Hz),6.94(1H,t,J=6.0Hz),3.65(2H,t,J=7.1H z),3.45-3.36(2H,m),2.49-2.44(2H,m),1.83-1.73(2H,m),1.67-1.56(2H,m),1.45(18H,s),0.92(3H,t,J=7.3Hz).
实施例7Example 7
[化学式46][Chemical Formula 46]
在40~45℃下将叔丁基-N-(叔丁氧基羰基)-N-(5-(2-(4-氰基苯胺基)-4-(丙基氨基)嘧啶-5-基)-4-戊烯-1-基)氨基甲酸酯60.0g的2-丁酮540mL溶液加入到37%盐酸111g、乙腈240mL及水300mL的混合液中。将2-丁酮60mL加入到得到的混合物中之后,在相同温度下搅拌6小时,在室温静置一晩。将反应混合物加热至45℃,加入25%氢氧化钠水溶液180mL。分离出有机层,在60℃依次加入水30mL及乙腈60mL,加入37%盐酸33.2g之后,在55~65℃下搅拌1小时。将2-丁酮300mL加入到反应混合物中,在0~10℃下搅拌2小时。过滤出固体物质,获得白色固体的4-((5-(5-氨基-1-戊炔-1-基)-4-(丙基氨基)嘧啶-2-基)氨基)苄腈/二盐酸盐/一水合物43.9g。A solution of 60.0 g of tert-butyl-N-(tert-butoxycarbonyl)-N-(5-(2-(4-cyanoanilino)-4-(propylamino)pyrimidin-5-yl)-4-penten-1-yl)carbamate in 540 mL of 2-butanone was added to a mixture of 111 g of 37% hydrochloric acid, 240 mL of acetonitrile, and 300 mL of water at 40-45°C. 60 mL of 2-butanone was added to the resulting mixture, which was then stirred at the same temperature for 6 hours and allowed to stand at room temperature overnight. The reaction mixture was heated to 45°C, and 180 mL of 25% aqueous sodium hydroxide solution was added. The organic layer was separated, and 30 mL of water and 60 mL of acetonitrile were added sequentially at 60°C. After adding 33.2 g of 37% hydrochloric acid, the mixture was stirred at 55-65°C for 1 hour. 300 mL of 2-butanone was added to the reaction mixture, and the mixture was stirred at 0-10°C for 2 hours. The solid substance was filtered out to obtain 43.9 g of 4-((5-(5-amino-1-pentyn-1-yl)-4-(propylamino)pyrimidin-2-yl)amino)benzonitrile dihydrochloride monohydrate as a white solid.
1H-NMR(DMSO-d6)δ:10.64(1H,brs),8.10(1H,s),8.03(3H,brs),7.89(2H,d,J=8.8Hz),7.79(2H,d,J=8.8Hz),3.42(2H,dd,J=6.6,14.4Hz),2.97-2.85(2H,m),2.62(2H,d,J=7.0Hz),1.92-1.77(2H,m),1.67-1.54(2H,m),0.92(3H,t,J=7.5Hz). 1 H-NMR (DMSO-d 6 )δ: 10.64(1H,brs),8.10(1H,s),8.03(3H,brs),7.89(2H,d,J=8.8Hz),7.79(2H,d,J=8.8Hz),3.42(2H,dd,J=6.6 ,14.4Hz),2.97-2.85(2H,m),2.62(2H,d,J=7.0Hz),1.92-1.77(2H,m),1.67-1.54(2H,m),0.92(3H,t,J=7.5Hz).
实施例8Example 8
[化学式47][Chemical Formula 47]
将4-((5-(5-氯-1-戊炔-1-基)-4-(丙基氨基)嘧啶-2-基)氨基)苄腈1.00g、二甲基亚砜6mL、邻苯二甲酰亚胺钾0.68g及碘化锂0.38g的悬浮液在40℃下搅拌19小时。在相同温度下加入50%2-丙醇水溶液10mL,冷却至室温。过滤出固体物质,获得淡黄色固体的4-((5-(5-(1,3-二氧代异二氢吲哚-2-基)-1-戊炔-1-基)-4-(丙基氨基)嘧啶-2-基)氨基)苄腈1.12g。A suspension of 1.00 g of 4-((5-(5-chloro-1-pentyn-1-yl)-4-(propylamino)pyrimidin-2-yl)amino)benzonitrile, 6 mL of dimethyl sulfoxide, 0.68 g of potassium phthalimide, and 0.38 g of lithium iodide was stirred at 40°C for 19 hours. 10 mL of 50% aqueous 2-propanol was added at the same temperature, and the mixture was cooled to room temperature. The solid was filtered to obtain 1.12 g of 4-((5-(5-(1,3-dioxoisoindolin-2-yl)-1-pentyn-1-yl)-4-(propylamino)pyrimidin-2-yl)amino)benzonitrile as a pale yellow solid.
1H-NMR(DMSO-d6)δ:9.79(1H,s),7.96(2H,d,J=8.8Hz),7.89-7.84(2H,m),7.84-7.79(2H,m),7.77(1H,s),7.68(2H,d,J=8.8Hz),6.95(3H,t,J=6.0Hz),3.75(3H,t,J=6.6Hz),3.45-3.25(2H,m),2.55-2.46(2H,m),1.96-1.85(2H,m),1.68-1.56(2H,m),0.93(3H,t,J=7.4Hz). 1 H-NMR (DMSO-d 6 )δ: 9.79(1H,s),7.96(2H,d,J=8.8Hz),7.89-7.84(2H,m),7.84-7.79(2H,m),7.77(1H,s),7.68(2H,d,J=8.8Hz),6.95(3H,t,J=6 .0Hz),3.75(3H,t,J=6.6Hz),3.45-3.25(2H,m),2.55-2.46(2H,m),1.96-1.85(2H,m),1.68-1.56(2H,m),0.93(3H,t,J=7.4Hz).
实施例9Example 9
[化学式48][Chemical Formula 48]
将4-((5-(5-(1,3-二氧代异二氢吲哚-2-基)-1-戊炔-1-基)-4-(丙基氨基)嘧啶-2-基)氨基)苄腈0.50g的乙二胺2.5mL溶液在80~90℃下搅拌3小时。将反应混合物冷却至室温,加入水0.2mL,在相同温度下搅拌4小时。将水10mL加入到反应混合物,在室温下搅拌30分钟。过滤出固体物质,获得淡黄色固体的4-((5-(5-氨基-1-戊炔-1-基)-4-(丙基氨基)嘧啶-2-基)氨基)苄腈0.31g。A solution of 0.50 g of 4-((5-(5-(1,3-dioxoisoindolin-2-yl)-1-pentyn-1-yl)-4-(propylamino)pyrimidin-2-yl)amino)benzonitrile in 2.5 mL of ethylenediamine was stirred at 80-90°C for 3 hours. The reaction mixture was cooled to room temperature, 0.2 mL of water was added, and the mixture was stirred at the same temperature for 4 hours. 10 mL of water was added to the reaction mixture, and the mixture was stirred at room temperature for 30 minutes. The solid material was filtered to obtain 0.31 g of 4-((5-(5-amino-1-pentyn-1-yl)-4-(propylamino)pyrimidin-2-yl)amino)benzonitrile as a light yellow solid.
MS m/z(M-H):333MS m/z(M-H): 333
1H-NMR(DMSO-d6)δ:9.78(1H,s),8.00-7.93(3H,m),7.71-7.65(2H,m),7.11-6.99(1H,m),3.55-3.15(2H,m),3.09(1H,dd,J=6.6,12.2Hz),2.66(2H,t,J=6.6Hz),2.53-2.43(2H,m),1.70-1.54(4H,m),0.92(3H,t,J=7.4Hz). 1 H-NMR (DMSO-d 6 )δ: 9.78(1H,s),8.00-7.93(3H,m),7.71-7.65(2H,m),7.11-6.99(1H,m),3.55-3.15(2H,m),3.09(1H, dd,J=6.6,12.2Hz),2.66(2H,t,J=6.6Hz),2.53-2.43(2H,m),1.70-1.54(4H,m),0.92(3H,t,J=7.4Hz).
实施例10Example 10
[化学式49][Chemical Formula 49]
将4-((5-(5-氨基-1-戊炔-1-基)-4-(丙基氨基)嘧啶-2-基)氨基)苄腈/二盐酸盐/一水合物40.0g、N-(叔丁氧基羰基)-N-甲基-L-丙氨酸22.9g、1-羟基苯并三唑一水合物2.88g及1-乙基-3-(3-二甲基氨基丙基)碳二亚胺盐酸盐21.6g依次加入到N,N-二异丙基乙胺43.8g的N-甲基-2-吡咯烷酮160mL溶液中,在20~30℃下搅拌7小时30分钟。将2-甲基四氢呋喃200mL加入到反应混合物中之后,依次加入10%氯化钠水溶液200mL及25%氢氧化钠水溶液43.4mL。分离出有机层,加入10%柠檬酸水溶液200mL之后,加入醋酸28.0mL。分离出有机层,以10%氯化钠水溶液清洗。40.0 g of 4-((5-(5-amino-1-pentyn-1-yl)-4-(propylamino)pyrimidin-2-yl)amino)benzonitrile dihydrochloride monohydrate, 22.9 g of N-(tert-butoxycarbonyl)-N-methyl-L-alanine, 2.88 g of 1-hydroxybenzotriazole monohydrate, and 21.6 g of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride were added sequentially to a solution of 43.8 g of N,N-diisopropylethylamine in 160 mL of N-methyl-2-pyrrolidone, and the mixture was stirred at 20-30°C for 7 hours and 30 minutes. After 200 mL of 2-methyltetrahydrofuran was added to the reaction mixture, 200 mL of a 10% aqueous sodium chloride solution and 43.4 mL of a 25% aqueous sodium hydroxide solution were added sequentially. The organic layer was separated, and 200 mL of a 10% aqueous citric acid solution was added, followed by 28.0 mL of acetic acid. The organic layer was separated and washed with 10% aqueous sodium chloride solution.
将水80mL加入到得到的有机层之后,在40℃加入37%盐酸74.1g,在相同温度下搅拌4小时30分钟。将水280mL加入到反应混合物,冷却至30℃之后,加入25%氢氧化钠水溶液116mL。在20~30℃下搅拌1小时之后,冷却至10℃,在相同温度下搅拌5小时。过滤出固体物质,获得淡黄色固体的(S)-N-(5-(2-((4-氰基苯基)氨基)-4-(丙基氨基)嘧啶-5-基)-4-戊烯-1-基)-2-丙酰胺/二水合物41.1g。After adding 80 mL of water to the resulting organic layer, 74.1 g of 37% hydrochloric acid was added at 40°C, and the mixture was stirred at the same temperature for 4 hours and 30 minutes. 280 mL of water was added to the reaction mixture, and after cooling to 30°C, 116 mL of 25% aqueous sodium hydroxide solution was added. After stirring at 20-30°C for 1 hour, the mixture was cooled to 10°C and stirred at the same temperature for 5 hours. The solid material was filtered to obtain 41.1 g of (S)-N-(5-(2-((4-cyanophenyl)amino)-4-(propylamino)pyrimidin-5-yl)-4-penten-1-yl)-2-propionamide/dihydrate as a pale yellow solid.
1H-NMR(DMSO-d6)δ:9.78(1H,s),8.00-7.94(3H,m),7.92(1H,t,J=6.0Hz),7.68(2H,d,J=8.8Hz),7.20(1H,t,J=5.6Hz),3.45-3.37(2H,m),3.29-3.23(2H,m),2.98-2.88(1H,m),2.45(2H,t,J=7.0Hz),2.20(3H,s),1.89(1H,brs),1.74-1.55(4H,m),1.11(3H,d,J=6.8Hz),0.92(3H,t,J=7.5Hz). 1 H-NMR (DMSO-d 6 )δ: 9.78(1H,s),8.00-7.94(3H,m),7.92(1H,t,J=6.0Hz),7.68(2H,d,J=8.8Hz),7.20(1H,t,J=5.6Hz),3.45-3.37(2H,m),3.29-3.23(2H, m),2.98-2.88(1H,m),2.45(2H,t,J=7.0Hz),2.20(3H,s),1.89(1H,brs),1.74-1.55(4H,m),1.11(3H,d,J=6.8Hz),0.92(3H,t,J=7.5Hz).
实施例11Example 11
[化学式50][Chemical Formula 50]
将1-乙基-3-(3-二甲基氨基丙基)碳二亚胺盐酸盐25.3g、乙基(羟基亚氨基)氰基乙酸酯18.7g及4-甲基吗啉40.0g依次加入到N,N-二甲基乙酰胺200mL之后,冷却至10℃,加入(S)-N-(5-(2-((4-氰基苯基)氨基)-4-(丙基氨基)嘧啶-5-基)-4-戊烯-1-基)-2-丙酰胺/二水合物40.0g及4-二甲基氨基巴豆酸盐酸盐21.8g,在10~15℃下搅拌5小时45分钟。将4-甲基-2-戊酮盐400mL加入到反应混合物中之后,加入15%氯化钠水溶液400mL。在室温静置一晩之后,将25%氢氧化钠水溶液48mL加入到反应混合物,在30~40℃下搅拌20分钟。分离出有机层,以10%氯化钠水溶液清洗。将水400mL及醋酸17.2mL依次加入到得到的有机层中。分离出水层,加入甲醇400mL,冷却至30℃之后,加入25%氢氧化钠水溶液35.1mL,在20~30℃下搅拌2小时。将反应混合物冷却至10℃,在0~10℃下搅拌2小时。过滤出固体物质,获得淡黄色固体的(S,E)-N-(1-((5-(2-((4-氰基苯基)氨基)-4-(丙基氨基)嘧啶-5-基)-4-戊炔-1-基)氨基)-1-氧代丙-2-基)-4-(二甲基氨基)-N-甲基-2-丁烯酰胺43.1g。25.3 g of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, 18.7 g of ethyl (hydroxyimino)cyanoacetate, and 40.0 g of 4-methylmorpholine were added sequentially to 200 mL of N,N-dimethylacetamide, then cooled to 10°C. 40.0 g of (S)-N-(5-(2-((4-cyanophenyl)amino)-4-(propylamino)pyrimidin-5-yl)-4-penten-1-yl)-2-propionamide/dihydrate and 21.8 g of 4-dimethylaminocroton hydrochloride were added, and the mixture was stirred at 10-15°C for 5 hours and 45 minutes. 400 mL of 4-methyl-2-pentanone salt was added to the reaction mixture, followed by 400 mL of 15% aqueous sodium chloride solution. After standing at room temperature overnight, 48 mL of 25% aqueous sodium hydroxide solution was added to the reaction mixture, and the mixture was stirred at 30-40°C for 20 minutes. The organic layer was separated and washed with a 10% aqueous sodium chloride solution. 400 mL of water and 17.2 mL of acetic acid were added sequentially to the resulting organic layer. The aqueous layer was separated, 400 mL of methanol was added, and after cooling to 30°C, 35.1 mL of a 25% aqueous sodium hydroxide solution was added, and the mixture was stirred at 20-30°C for 2 hours. The reaction mixture was cooled to 10°C and stirred at 0-10°C for 2 hours. The solid material was filtered to obtain 43.1 g of (S,E)-N-(1-((5-(2-((4-cyanophenyl)amino)-4-(propylamino)pyrimidin-5-yl)-4-pentyn-1-yl)amino)-1-oxopropan-2-yl)-4-(dimethylamino)-N-methyl-2-butenamide as a pale yellow solid.
产业上的可利用性Industrial applicability
本发明的制造方法作为具有优异的FLT3抑制活性,作为医药品的原料药有用的含氮杂环化合物的工业制造方法有用,本发明的化合物作为用于具有优异的FLT3抑制活性,作为医药品的原料药有用的含氮杂环化合物的工业制造方法的中间体有用。The production method of the present invention is useful as an industrial production method for nitrogen-containing heterocyclic compounds that have excellent FLT3 inhibitory activity and are useful as raw materials for pharmaceuticals. The compound of the present invention is useful as an intermediate for the industrial production method of nitrogen-containing heterocyclic compounds that have excellent FLT3 inhibitory activity and are useful as raw materials for pharmaceuticals.
Claims (13)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015-141034 | 2015-07-15 | ||
| JP2015141034A JP6412471B2 (en) | 2015-07-15 | 2015-07-15 | Process for producing nitrogen-containing heterocyclic compound and intermediate thereof |
| PCT/JP2016/070758 WO2017010535A1 (en) | 2015-07-15 | 2016-07-14 | Production method for nitrogen-containing heterocyclic compound, and intermediate of said nitrogen-containing heterocyclic compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1245268A1 HK1245268A1 (en) | 2018-08-24 |
| HK1245268B true HK1245268B (en) | 2021-04-01 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105683167B (en) | Salt of nitrogen-containing heterocyclic compound or its crystal, pharmaceutical composition and FLT3 inhibitor | |
| US10562862B2 (en) | Method for manufacturing nitrogen-containing heterocyclic compound and intermediate of same | |
| US7494993B2 (en) | Amide derivatives of 7-amino-3-phenyl-dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents | |
| JP6787398B2 (en) | Method for producing monomer for single-stranded nucleic acid molecule | |
| CN102137856A (en) | 2, 4' -bipyridine compounds as protein kinase D inhibitors useful for the treatment of IA heart failure and cancer | |
| CN104520278A (en) | A process for the preparation of an intermediate for a triazolopyrimidine carbonucleoside | |
| HK1245268B (en) | Production method for nitrogen-containing heterocyclic compound, and intermediate of said nitrogen-containing heterocyclic compound | |
| HK1219946B (en) | Nitrogen-containing heterocyclic compound salt or crystal thereof, pharmaceutical composition, and flt3 inhibitor | |
| JPWO2005035493A1 (en) | Process for producing aminopyrrolidine derivative and intermediate compound | |
| WO2002098872A1 (en) | Isoindolines and process for preparation thereof | |
| JP2004175737A (en) | Pharmaceutical composition |